Medifirst Solutions 10-Q 15 Nov 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 13, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Medifirst Solutions, Inc.
Entity Central Index Key	1,522,704
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		138,018,335

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current Assets:
Cash	$ 134,079	$ 156,958
Accrued interest receivable	2,523
Inventory	50,000	50,000
Total current assets	186,602	206,958
Property, Plant and Equipment, net	1,389	2,159
Other Assets
Security Deposit	650
Intangible Asset -License Agreement, net	141,252
Total other assets	141,902
Total Assets	329,893	209,117
Liabilities
Accounts payable and accrued expenses	76,145	123,648
Accrued expenses - officer's compensation	395,526	370,000
Due to related party	8,921	8,921
Loans payable - stockholders	12,536	24,449
Note Payable for license agreement	150,000
Convertible notes payable	293,930	180,393
Derivative Liabilities	363,977	157,617
Total current liabilities	1,301,035	865,028
Commitments & Contingencies (Note 8)
Stockholders' Equity:
Common stock, $0.0001 par value; 1,500,000,000 shares authorized, 110,366,413 and 35,101,750 shares issued and outstanding, respectively	11,037	3,510
Additional paid in capital	797,362	310,183
Accumulated deficit	(1,779,549)	(969,609)
Total Stockholders' Equity	(971,142)	(655,911)
Total Liabilities & Stockholders' Equity	329,893	209,117
Series A preferred stock
Stockholders' Equity:
Preferred stock	5	5
Series B convertible preferred stock
Stockholders' Equity:
Preferred stock	$ 3

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	110,366,413	35,101,750
Common stock, shares outstanding	110,366,413	35,101,750
Series A preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	50,000	50,000
Preferred stock, shares outstanding	50,000	50,000
Series B convertible preferred stock
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	50,000	50,000
Preferred stock, shares issued	26,100	0
Preferred stock, shares outstanding	26,100	0

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Statements of Operations [Abstract]
Consulting fee revenue				$ 1,858
Product sales, net
Total Revenues				1,858
Cost of goods sold				5,150
Gross income				(3,292)
Expenses:
Officer's compensation	25,000	25,000	75,000	75,000
Impairment of Trademark		20,000		20,000
Advertising and promotion	12,193	3,092	32,114	4,513
Computer and internet	275	957	463	1,796
Consulting fees	89,667	16,000	124,510	18,125
Professional fees	49,486	35,389	110,381	43,534
Provision for bad debts				2,255
Rent	1,946	1,872	6,039	6,087
Travel	588		1,744
Lab testing			32,400
Dues and subscriptions	296		10,575
Other	12,672	1,657	33,760	15,539
Total Expenses	192,123	103,967	426,986	186,849
Net loss from Operations before other income, expenses	(192,123)	(103,967)	(426,986)	(190,141)
Other Income (expenses)
Interest expense	(138,665)	(4,196)	(416,734)	(5,018)
Interest income			2,523
Change in Fair Value -Derivatives	(112,720)		31,256
Net loss before provision for income tax	(443,508)	(108,163)	(809,941)	(195,159)
Provision for income taxes
Net Loss	$ (443,508)	$ (108,163)	$ (809,941)	$ (195,159)
Loss per common share - Basic and fully diluted	$ (0.007)	$ (0.004)	$ (0.014)	$ (0.008)
Weighted average number of shares outstanding - Basic and fully diluted	59,434,929	30,587,838	57,864,173	25,158,124

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)	Total	Common Stock	Preferred Class A	Preferred Class B	Additional Paid in Capital	Accumulated Deficit
Balance at Dec. 31, 2014	$ (364,477)	$ 2,248	$ 5		$ 258,755	$ (625,485)
Balance, shares at Dec. 31, 2014		22,481,750	50,000
Issuance of common shares upon partial conversion of note at $0.0001 per share	2,000	$ 200			1,800
Issuance of common shares upon partial conversion of note at $0.0001 per share, shares		2,000,000
Cancellation of common shares		$ (50)			$ 50
Cancellation of common shares, shares		(500,000)
Issuance of common shares upon partial conversion of note at $0.0005 per share	400	$ 80			$ 320
Issuance of common shares upon partial conversion of note at $0.0005 per share, shares		800,000
Contribution to additional paid in capital	1,050				1,050
Issuance of common shares upon partial conversion of note at $0.0005 per share	150	$ 30			120
Issuance of common shares upon partial conversion of note at $0.0005 per share, shares		300,000
Issuance of common shares upon partial conversion of note at $0.0005 per share	500	$ 100			400
Issuance of common shares upon partial conversion of note at $0.0005 per share, shares		1,000,000
Issuance of common shares upon partial conversion of note at $0.0005 per share	500	$ 100			400
Issuance of common shares upon partial conversion of note at $0.0005 per share, shares		1,000,000
Contribution to additional paid in capital	1,575				1,575
Issuance of common shares upon partial conversion of note at $0.0005 per share	1,900	$ 380			1,520
Issuance of common shares upon partial conversion of note at $0.0005 per share, shares		3,800,000
Issuance of common shares to acquire subsidiary at $0.015 per share	20	$ 2			18
Issuance of common shares to acquire subsidiary at $0.015 per share, shares		20,000
Issuance of common shares for services $0.01 per share	35,000	$ 350			34,650
Issuance of common shares for services $0.01 per share, shares		3,500,000
Contribution to additional paid in capital	1,575				1,575
Issuance of common shares to investor $0.01 per share	20	$ 20
Issuance of common shares to investor $0.01 per share, shares		200,000
Additional paid in capital on debt discount related to the intrinsic beneficial conversion feature	3,000				3,000
Issuance of common shares for services $0.01 per share	5,000	$ 50			4,950
Issuance of common shares for services $0.01 per share, shares		500,000
Net loss	(344,124)					(344,124)
Balance at Dec. 31, 2015	(655,911)	$ 3,510	$ 5		310,183	(969,609)
Balance, shares at Dec. 31, 2015		35,101,750	50,000
Issuance of common shares upon partial conversion of note at $0.00275 per share	3,011	$ 110			2,901
Issuance of common shares upon partial conversion of note at $0.00275 per share, shares		1,095,036
Issuance of common shares upon partial conversion of note at $0.00275 per share	3,535	$ 129			3,406
Issuance of common shares upon partial conversion of note at $0.00275 per share, shares		1,285,560
Issuance of common shares upon partial conversion of note at $0.003355 per share	3,041	$ 91			2,950
Issuance of common shares upon partial conversion of note at $0.003355 per share, shares		906,533
Issuance of common shares upon partial conversion of note at $0.00275 per share	750	$ 150			600
Issuance of common shares upon partial conversion of note at $0.00275 per share, shares		1,500,000
Issuance of Series B Preferred shares as part consideration for license agreement	3			$ 3
Issuance of Series B Preferred shares as part consideration for license agreement, shares				25,000
Issuance of Series B Preferred shares as payment for inventory	50,000			$ 1	49,999
Issuance of Series B Preferred shares as payment for inventory, shares				10,000
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock	(1)	$ 170		$ (1)	(170)
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock, shares		1,700,000		(3,400)
Additional paid in capital from derivative liability on debt conversion	10,152				10,152
Net loss	(334,613)					(334,613)
Balance at Mar. 31, 2016	(920,034)	$ 4,160	$ 5	$ 3	380,021	(1,304,222)
Balance, shares at Mar. 31, 2016		41,588,879	50,000	31,600
Balance at Dec. 31, 2015	(655,911)	$ 3,510	$ 5		310,183	(969,609)
Balance, shares at Dec. 31, 2015		35,101,750	50,000
Net loss	(809,941)
Balance at Sep. 30, 2016	(971,142)	$ 11,037	$ 5	$ 3	797,362	(1,779,549)
Balance, shares at Sep. 30, 2016		110,366,413	50,000	26,100
Balance at Mar. 31, 2016	(920,034)	$ 4,160	$ 5	$ 3	380,021	(1,304,222)
Balance, shares at Mar. 31, 2016		41,588,879	50,000	31,600
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock	0	$ 170		$ 0	(170)
Issuance of common shares upon conversion of 3,400 shares of Series B Preferred Stock, shares		1,700,000		(3,400)
Issuance of common shares upon partial conversion of note at $.0033 per share	5,230	$ 158			5,072
Issuance of common shares upon partial conversion of note at $.0033 per share, shares		1,584,873
Issuance of common shares upon partial conversion of note at $.0033 per share	7,240	$ 219			7,021
Issuance of common shares upon partial conversion of note at $.0033 per share, shares		2,194,200
Issuance of common shares upon partial conversion of note at $.0044 per share	8,800	$ 200			8,600
Issuance of common shares upon partial conversion of note at $.0044 per share, shares		2,000,000
Issuance of common shares upon conversion of 3,900 shares of Series B Preferred Stock	0	$ 195		$ 0	(195)
Issuance of common shares upon conversion of 3,900 shares of Series B Preferred Stock, shares		1,950,000		(3,900)
Issuance of common shares to extend due date of a note payable at par value per share	30	$ 30
Issuance of common shares to extend due date of a note payable at par value per share, shares		300,000
Issuance of Series B Preferred shares as consideration for trademark purchase	19,999			$ 0	19,999
Issuance of Series B Preferred shares as consideration for trademark purchase, shares				4,000
Issuance of common shares upon partial conversion of note at $.0029 per share	7,288	$ 250			7,038
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,500,000
Issuance of common shares upon partial conversion of note at $.0038 per share	3,058	$ 78			2,980
Issuance of common shares upon partial conversion of note at $.0038 per share, shares		783,062
Issuance of common shares upon conversion of 2,200 shares of Series B Preferred Stock	0	$ 110		$ 0	(110)
Issuance of common shares upon conversion of 2,200 shares of Series B Preferred Stock, shares		1,100,000		(2,200)
Issuance of common shares upon partial conversion of note at $.0036 per share	2,800	$ 77			2,723
Issuance of common shares upon partial conversion of note at $.0036 per share, shares		768,026
Issuance of common shares upon partial conversion of note at $.0028 per share	2,400	$ 85			2,315
Issuance of common shares upon partial conversion of note at $.0028 per share, shares		853,643
Issuance of common shares for services $0.01 per share	5,000	$ 50			4,950
Issuance of common shares for services $0.01 per share, shares		500,000
Additional paid in capital from derivative liability on debt conversion	42,092				42,092
Net loss	(31,819)					(31,819)
Balance at Jun. 30, 2016	(847,915)	$ 5,783	$ 5	$ 3	482,336	(1,336,041)
Balance, shares at Jun. 30, 2016		57,822,683	50,000	26,100
Issuance of common shares upon partial conversion of note at $.002915 per share	3,800	$ 136			3,664
Issuance of common shares upon partial conversion of note at $.002915 per share, shares		1,356,747
Issuance of common shares upon partial conversion of note at $..002915 per share	7,288	$ 250			7,038
Issuance of common shares upon partial conversion of note at $..002915 per share, shares		2,500,000
Issuance of common shares upon partial conversion of note at $.0029 per share	6,420	$ 221			6,199
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,213,714
Issuance of common shares upon partial conversion of note at $..002915 per share	8,940	$ 319			8,621
Issuance of common shares upon partial conversion of note at $..002915 per share, shares		3,193,941
Issuance of common shares upon partial conversion of note at $..002915 per share	9,270	$ 318			8,952
Issuance of common shares upon partial conversion of note at $..002915 per shares, shares		3,180,000
Issuance of common shares upon partial conversion of note at $.0029 per share	8,688	$ 300			8,388
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,995,816
Issuance of common shares upon partial conversion of note at $.002915 per share	9,375	$ 335			9,040
Issuance of common shares upon partial conversion of note at $.002915 per share, shares		3,352,874
Issuance of common shares upon partial conversion of note at $..002915 per share	3,480	$ 119			3,360
Issuance of common shares upon partial conversion of note at $..002915 per share, shares		1,194,500
Issuance of common shares upon partial conversion of note at $..00352 per share	11,235	$ 333			10,902
Issuance of common shares upon partial conversion of note at $..00352 per share, shares		3,333,073
Issuance of common shares upon partial conversion of note at $.0039 per share	10,450	$ 269			10,181
Issuance of common shares upon partial conversion of note at $.0039 per share, shares		2,693,624
Issuance of common shares upon partial conversion of note at $.003465 per share	10,000	$ 289			9,711
Issuance of common shares upon partial conversion of note at $.003465 per share, shares		2,886,003
Issuance of common shares upon partial conversion of note at $.0029 per share	6,000	$ 223			5,777
Issuance of common shares upon partial conversion of note at $.0029 per share, shares		2,226,772
Issuance of common shares upon conversion of note payable at $.0005 per share	1,200	$ 240			960
Issuance of common shares upon conversion of note payable at $.0005 per share, shares		2,400,000
Issuance of common shares for services $.0092 per share	36,800	$ 400			36,400
Issuance of common shares for services $.0092 per share, shares		4,000,000
Issuance of common shares for services $.0092 per share	27,600	$ 300			27,300
Issuance of common shares for services $.0092 per share, shares		3,000,000
Issuance of common shares for services $.0083 per share	16,600	$ 200			16,400
Issuance of common shares for services $.0083 per share, shares		2,000,000
Issuance of common shares for services $.00083 per share	16,600	$ 200			16,400
Issuance of common shares for services $.00083 per share, shares		2,000,000
Issuance of common shares for services $.0078 per share	3,900	$ 50			3,850
Issuance of common shares for services $.0078 per share, shares		500,000
Issuance of common shares for services $.0065 per share	13,000	$ 200			12,800
Issuance of common shares for services $.0065 per share, shares		2,000,000
Issuance of common shares upon conversion of note payable at $.001 per share	3,000	$ 300			2,700
Issuance of common shares upon conversion of note payable at $.001 per share, shares		3,000,000
Issuance of common shares upon conversion of note payable at $.0028 per share	7,248	$ 251			6,997
Issuance of common shares upon conversion of note payable at $.0028 per share, shares		2,516,666
Additional paid in capital from derivative liability on debt conversion	99,387				99,387
Net loss	(443,508)					(443,508)
Balance at Sep. 30, 2016	$ (971,142)	$ 11,037	$ 5	$ 3	$ 797,362	$ (1,779,549)
Balance, shares at Sep. 30, 2016		110,366,413	50,000	26,100

Consolidated Statement of Stoc6

Consolidated Statement of Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended			12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
Issuance of common shares upon partial conversion of note, share price	$ 0.002915			$ 0.0001
Issuance of common shares upon partial conversion of note, share price one	0.002915			0.0005
Issuance of common shares upon partial conversion of note, share price two	0.0029			0.0005
Issuance of common shares upon partial conversion of note, share price three	0.002915			0.0005
Issuance of common shares upon partial conversion of note, share price four	0.002915			0.0005
Issuance of common shares upon partial conversion of note, share price five	0.0029			0.0005
Issuance of common shares to acquire subsidiary, share price				0.015
Issuance of common shares for services , share price	0.0092
Issuance of common shares upon partial conversion of note, share price six	0.002915		$ 0.00275
Issuance of common shares upon partial conversion of note, share price seven	0.002915		0.00275
Issuance of common shares upon partial conversion of note, share price eight	0.00352		0.003355
Issuance of common shares upon partial conversion of note, share price nine	0.0039		$ 0.00275
Issuance of common shares upon partial conversion of note, share price ten	0.003465	$ 0.0033
Issuance of common shares upon partial conversion of note, share price eleven	0.0029	0.0033
Issuance of common shares upon partial conversion of note, share price twelve	0.0005	0.0044
Issuance of common shares upon partial conversion of note, share price thirteen	0.001	0.0029
Issuance of common shares upon partial conversion of note, share price fourteen	0.0028	0.0038
Issuance of common shares upon partial conversion of note, share price fifteen		0.0036
Issuance of common shares upon partial conversion of note, share price sixteen		0.0028
Issuance of common shares for services, share price one	0.0092
Issuance of common shares for services, share price two	0.0083
Issuance of common shares for services, share price three	0.00083
Issuance of common shares for services, share price four	0.0078
Issuance of common shares for services, share price five	$ 0.0065
Common Stock
Issuance of common shares for services , share price				0.01
Issuance of common shares to investor, share price				0.01
Issuance of common shares for services, share price one		$ 0.01		$ 0.01
Series B convertible preferred stock
Issuance of common shares upon conversion of Series B Preferred Stock		3,400	3,400
Issuance of common shares upon conversion of Series B Preferred Stock, one		3,900
Issuance of common shares upon conversion of Series B Preferred Stock, two		2,200

Consolidated Statement of Cash

Consolidated Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (809,941)	$ (195,159)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation & amortization expense	9,520	1,247
Impairment loss of trademark		20,000
Provision for doubtful accounts		2,255
Stock Based Compensation	119,530	35,000
Change in assets and liabilities
Accrued Interest Receivable	(2,523)
Accounts payable and accrued expenses	48,021	118,659
Security deposit	(650)	1,065
Deferred financing costs		(5,708)
Notes payable derivatives	412,327
Stockholder's loan	(11,913)
Prepaid expenses		1,125
Inventory		(45,000)
Net cash used by operating activities	(235,629)	(66,516)
Cash flows from investing activities:
None
Net cash used by investing activities
Cash flows from financing activities:
Repayment of bank overdraft		(4,197)
Proceeds from stockholders' loans		37,102
Proceeds from stockholder contribution		4,200
Proceeds from related party advances		2,984
Repayment of stockholders' loan		(30,221)
Proceeds from sale of Convertible notes payable	212,750	200,000
Net cash provided by financing activities	212,750	209,868
Net increase (decrease) in cash	(22,879)	143,352
Cash at beginning of period	156,958
Cash at end of period	134,079	143,352
Cash paid during the period for:
Interest		551
Income taxes	1,014	550
Non-cash investing and financing activities:
Shares issued upon acquisiation of Subsidiary		20
Cancellation of shares		50
Shares issued upon settlement of debt		5,450
Common stock issued for note interest and note conversions	99,387
Preferred stock issued for debt settlement and license agreement	$ 70,001

Nature of Operations and Summar

Nature of Operations and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Note 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization Medifirst Solutions, Inc. ("MSI" or the "Company") was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company's products, developing the Company's models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company's offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. In July 2016, Medifirst, in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.The Company is actively putting together a sales and distribution team to offer our lasers in the US market. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company's president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. ("MLM") with the total purchase price of 20,000 shares of the Company's common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology. Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such principles and regulations of the Securities and Exchange Commission for Form 10-Q. All adjustments, consisting of normal recurring adjustments, have been made which, in the opinion of management, are necessary for a fair presentation of the results of interim periods. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for a full year because of, among other things, seasonality factors in the retail business. The unaudited financial statements contained herein should be read in conjunction with the audited financial statements and notes thereto for the fiscal year ended December 31, 2015. Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on prior year net income or shareholders’ equity. Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company's historical return experience. Revenue is presented net of returns. Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management's estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of September 30, 2016 or December 31, 2015. Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value. Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years. Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company's wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in the quarter ended September 2015. Intangible Asset- Licensing Agreement On March 8th 2016, the company, through it's sole wholly-owned subsidiary ("Licensee"), entered into a Product and Know-How License Agreement ("Agreement") with a Florida Corporation ("Licensor"). The license provides with respect to the Technology, Licensor hereby grants to Licensee an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and - sublicense the Technology; and - prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet as they are based on sales for which the company has none. The licensing agreement is for a ten year period effective from March 8th 2016. The cost of the licensing agreement is being amortized over it's ten-year period and charged to income on a straight-line basis. Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company early-adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements). Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt. Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates. Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values. Segment Information The Company follows Accounting Standards Codification ("ASC") 280, "Segment Reporting". The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations. Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive. Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of September 30, 2016, and does not expect this to change significantly over the next 12 months. Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance. Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At September 30, 2016, the Company had $134,079 in cash equivalents and $156,958 in cash equivalents a December 31, 2015. Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company for the fiscal year beginning June 1, 2017. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In November 2015, FASB issued ASU 2015-17 - Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes which simplifies the presentation of deferred income taxes. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In February 2015, FASB issued ASU 2015-02 Consolidation (Topic 810) Amendments to the Consolidation Analysis. The amendments in this Update affect reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. The amendments in this Update are effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material.

Property, Plant and Equipment (

Property, Plant and Equipment (Net)	9 Months Ended
	Sep. 30, 2016
Property, Plant and Equipment (Net) [Abstract]
PROPERTY, PLANT AND EQUIPMENT (NET)	Note 2. PROPERTY, PLANT AND EQUIPMENT (NET) Equipment is recorded at cost and consisted of the following at September 30, 2016 and December 31, 2015: 2016 2015 Computer equipment $ 8,314 $ 8,314 Less: accumulated depreciation (6,925 ) (6,155 ) $ 1,389 $ 2,159 Depreciation expense for the three - and nine-month periods ended September 30, 2016 was $201 and $770, respectively, and for the three - and nine-month periods ended September 30, 2015 was $416 and $1,247, respectively.

Due to Related Party

Due to Related Party	9 Months Ended
	Sep. 30, 2016
Due to Related Party [Abstract]
DUE TO RELATED PARTY	Note 3. DUE TO RELATED PARTY The Company was indebted to a related party through common management in the amount of $8,921 at September 30, 2016 and December 31, 2015, respectively. The loan bears no interest and is payable on demand. See Note 10 for additional related party transactions.

Loans Payable - Stockholders

Loans Payable - Stockholders	9 Months Ended
	Sep. 30, 2016
Loans Payable - Stockholders/Convertible Notes Payable [Abstract]
LOANS PAYABLE - STOCKHOLDERS	Note 4. LOANS PAYABLE - STOCKHOLDERS During the periods ended September 30, 2016 and 2015 a stockholder of the Company advanced the Company $-0- and $20,670 respectively. The loan has a balance of $10,936 at September 30, 2016 and a balance of $20,899 as of December 31, 2015. The loan bears no interest and is payable on demand. In December 2012, the Company issued a promissory note to a stockholder in the amount of $5,000 with interest at 10% per annum. Principal and interest were due and payable on June 2, 2013. In April 2014, the note was amended to provide the note holder with the option to convert the note to the Company's common stock at $0.0001 per share. Subsequently, in 2014, in a private transactions, the note holder transferred $2,500 of note principal to third parties and the new holders converted their holdings into 2,500,000 shares of the Company's common stock. During 2015, the original note holder transferred an additional $2,400 of note principal to third parties who converted their holdings into 2,400,000 shares of the Company's common stock. At September 30, 2016 and December 31, 2015, the loan had balance was $100 and $100, respectively. At September 30, 2016 and December 31, 2015, the Company was indebted to a stockholder in the amount of $1,500 and $1,500, respectively. The loan has an interest rate of 26.7%. Principal and accrued interest were due and payable on January 1, 2014. In February 2016, the Company issued a promissory note to a stockholder in the amount of $7,000 with interest at the rate of 6% per annum. On September 6, 2016 the note holder converted the entire principal balance and accrued interest into common stock and therefore at September 30, 2016 there is no principal balance remaining on the note.

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Sep. 30, 2016
Loans Payable - Stockholders/Convertible Notes Payable [Abstract]
CONVERTIBLE NOTES PAYABLE	Note 5. CONVERTIBLE NOTES PAYABLE Note Payable-BS In March 2011, the Company issued $800 aggregate principal amount of 6% convertible notes due in January 2012. Interest on the notes accrue at the rate of 6% per annum and are payable when the notes mature. The notes matured prior to conversion but have not been repaid. Interest continues to accrue at the rate of 6% per annum. The holder of one of the notes converted $110 of note principal into 1,100,000 shares of common stock as follows: Principal Date of Conversion Amount Converted Conversion Shares June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000 In August 2013, in a private transaction, the same note holder transferred $330 of the remaining note principal plus $55 in accrued interest to a third party. In August 2013, in a private transaction, the new note holder transferred $5 of the remaining note principal to a third party who then converted the note into 50,000 shares of common stock. In September 2013, the new note holder converted $100 of note principal into 1,000,000 shares of common stock. In September 2013, in a private transaction, the new note holder transferred $35 of the remaining note principal to a third party who then converted the note into 350,000 shares of common stock. In November and December 2013, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Principal Date of Conversion Amount Converted Conversion Shares November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000 In March and April 2014, the new note holder converted an additional $90 of note principal into 900,000 shares of common stock as follows: Principal Date of Conversion Amount Converted Conversion Shares March 2014 $ 5 0 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000 Subsequent to these conversions there remains $125 in note principal outstanding at September 30, 2016. Note Payable-SF In July 2013, the holder of the second note converted $240 of note principal into 400,000 shares of the Company's common stock at $0.0006 per share. At September 30, 2016 and December 31 2015, the note had a remaining principal balance of $60 and $60, respectively. At any time on or after the maturity date, the holders of the notes, have the option of converting any of the unpaid principal and interest into the Company's common stock. The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 11,025,605 shares at September 30, 2016 and 3,506,665 shares at December 31, 2015. Note Payable-RK In May 2012, the Company issued a $25,000 6% per annum note that matured in November 2012. In December 2012 the note was amended to be a convertible note. Interest on the note accrues interest at 6% per annum and is payable when the note matures. The holder of the $25,000 note had the option of converting it at any time prior to maturity. The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock. The holder of the note converted $1,010 of note principal into 1,010,000 shares of common stock as follows: Principal Date of Conversion Amount Converted Conversion Shares December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000 In July 2013, the Company retired $14,000 of note principal in payment for consulting services provided to the note holder. In July 2013, the note holder converted $300 of note principal into 300,000 shares of the Company's common stock. In July 2013, in a private transaction, the note holder transferred the remaining note principal balance of $9,690 to a third party (See Note Payable-NW Note Payable-NW After receiving the transfer of the principal balance of $9,690 in July 2013 in the private transaction noted in Note Payable-RK In October 2013, the note holder converted $400 of note principal into 400,000 shares of the Company's common stock at $0.001 per share. In October 2014, the note holder converted $1,100 of note principal into 1,100,000 of the Company's common stock.The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 11,025,605 shares at September 30, 2016 and 3,506,665 shares at December 31, 2015. In August 2016, the note holder converted $3,000 of note principal into 3,000,000 shares of the Company's common stock. At September 30, 2016 and December 31, 2015, the remaining principal balance on this portion of the note is $715 and $3,715 respectively. Note Payable-MC #1 In August 2013, the note holder/stockholder who received the $4,475 in principal from the aforementioned noteholder, converted $700 of note principal into 700,000 shares of the Company's common stock at $0.001 per share. In October 2013, in a private transaction, this note holder transferred $1,000 of note principal to a third party of which $700 was converted into 700,000 shares in June 2014. The remaining principal balance on this portion of the note at September 30, 2016 and December 31, 2015 is $2,075. The note holder has the option of converting the balance at any time with the approval of the Board of Directors. The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 11,025,605 shares at September 30, 2016 and 3,506,665 shares at December 31, 2015. Note Payable-MC #2 In April 2015, the Company issued a $3,000 8% per annum note that matures in October 2015. The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share. Interest on the note accrues interest at 8% per annum and is payable when the note matures. The entire pricipal balnce in the amount of $3,000 remains due on the note at September 30, 2016 and December 31, 2015 Convertible Note Payable-VV to LG (8%) #1 In July 2015, the Company issued a convertible note payable in the principal amount of $59,000. The note matured in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. Through a series of conversions during the nine months ended September 30, 2016, the note holder converted all the entire note principal and accrued interest into common stock thereby leaving no principal balance remaining on the note at September 30, 2016. Convertible Note Payable-VV (8%) #2 In August 2015, the Company issued a convertible note payable in the principal amount of $38,000. The note matured in March 2016 and bears interest at 8%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date. The entire principal balance in the amount of $38,000 remains due on the note as of September 30, 2016. Convertible Note Payable-LGC (8%) On October 8, 2015, the Company issued a convertible note payable in the principal amount of $31,000 with an Original Issue Discount of $1,500. The note matures on October 8, 2016 and bears interest at 8%. The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date. On September 21, 2016 the note holder converted $6,000 of the principal note into common stock thereby leaving a remaining principal balance of $25,000 due on the note at September 30, 2016. The matured note was not paid off by the Company on October 8, 2016 and the noteholder intends to convert the note balance into common stock. Debenture Payable - (5%) B (Original $100K) In June 2015, the Company issued a convertible note payable in the principal amount of $100,000. The note matures in December 2015 and bears interest at 5%. Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date. The remaining principal balance on the note at June 30, 2016 was $40,000 after a private sale of $60,000 in principal and deemed accrued interest on May 2, 2016 to another investor and the issuance of a replacement note by the Company - see below- Convertible Note Payable-SO-B (8%) (Original $60k) On September 27, 2016 the remaining $40,000 in principal balance and accrued interest on the note was sold in a private transaction to another investor and the Company issued a replacement note in the amount of $50,000. Both of the above noted transactions which took place on May 2, 2016 and September 27, 2016 respectively, resulted in a loss on the extinguishment of the original debt in the amount of $4,733 from deeming accrued interest in excess of actual accruals. This loss is reported in the statement of operations for the quarter and nine months ended September 30, 2016. As a result of the aforementioned transactions and conversions, there is no principal balance remaining on the original $100,000 note as of September 30, 2016. Convertible Note Payable-SO-B (8%) (Original $60k) On May 2, 2016, the Company issued to an Investor a replacement redeemable convertible note in the principal amount of $60,000 ("the Replacement Note"). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000 The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. Any unamortized original issue discount and deferred financing costs from the original note was expensed upon replacement. The derivative discount and liability on the original note was appropriately accounted for upon replacement and a new derivative discount and liability for the replacement note appropriately recorded. During the months of May, June, July and September 2016, the holder of the aforementioned $60,000 Replacement Note converted $37,579 in principal to common stock leaving a principal balance payable of $22,421 on the note as of September 30, 2016. Convertible Note Payable-CB (5%) (Original $35k) On October 15, 2015 the Company issued a convertible note payable in the principal amount of $35,000 with an Original Issue Discount of $5,000. The note matures on October 15, 2016 and bears interest at 5%. The note holder has has the right at any time on or after the day that is six months from October 15, 2015 to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 55% of the lowest market trading prices during the 20 days prior to the conversion date. During the months of May, June and July 2016, the holder of the above $35,000 Note converted all of the principal to common stock thereby leaving no principal balance payable on the note as of September 30, 2016. Convertible Notes Payable-LGC (8%) On January 7 2016, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”) for the sale of convertible redeemable notes in aggregate principal amount of $251,803. On January 7, 2016, the Company and the Investor conducted the first closing under the Purchase Agreement, pursuant to which the Company issued to the Investor (i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the “$105K Note”); and (ii) a convertible redeemable note in principal amount of $50,000 (the “$50K Note” and together with the $105K Note, the “Notes”). Under the Purchase Agreement, on March 15, 2016 and June 15, 2016, the Company and the Investor conducted additional closings for the sale and purchase of additional notes having the same terms as the Notes in principal amounts equal to $50,000 and $46, 803, respectively (see Convertible Notes Payable-LGC (8%) BEN Convertible Notes Payable-LGC (8%) BEN In consideration for the issuance of the $105K Note, on January 13, 2016, the Company received net proceeds (after deducting the original issue discount and legal fees) in the amount of $75,697. In consideration for the issuance of the $50K Note, the Investor issued to the Company a $50,000 fully-collateralized secured promissory note (the “Investor Note”), pursuant to which the Investor agreed to pay the Company $50,000 on or before April 30, 2016. The Notes, which are due on January 7, 2017, bear interest at the rate of 8% per annum. Subject to a beneficial ownership limitation equal to 9.99%, principal and interest on the Notes is convertible into shares of the Company’s common stock (“Common Stock”) at a conversion price equal to 55% of the lowest trading price of Common Stock during the 20 trading day period prior to conversion. In accordance with the terms of the Purchase Agreement, the investor and the Company closed on the two outstanding notes ($50,000 and $46,803) in May and June 2016. The Company received the cash funding. As of September 30, 2016 the entire remaining principal balances of $50,000 and $46,803 respectively are outstanding. Convertible Notes Payable-SO (8%) On May 2, 2016, the Company issued to an Investor a convertible redeemable note in the principal amount of $57,750 ("the Note"). The Note, which matures on May 2, 2017, pays interest at the rate of 8% per annum. The note contains a 10% original issue discount. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. The entire principal balance in the amount of $57,750 was outstanding on the note at September 30, 2016. The Company’s convertible notes payable and the related derivative liabilities, derivative discount, deferred financing costs and original-issue discount are presented in the financial statements at September 30, 2016 as follows: Remaining Original Deferred Total Convertible Principal Issue Derivative Financing Notes Derivative Debt Amount Discount Discount Costs Payable Liability Note Payable - BS $ 125 - - - $ 125 - Note Payable - SF 60 - - - 60 - Note Payable - MC #1 2,075 - - - 2,075 - Note Payable - NW 715 - - - 715 - Note Payable - MC #2 3,000 - - - 3,000 - Debenture Payable (5%) - B (Original $100K) 40,000 - - (30 ) 39,970 - Convertible Note Payable - LGC (8%) 105,000 - (40,028 ) (5,414 ) 59,558 82,223 Convertible Note Payable - LGC (8%) BEN 50,000 - (27,273 ) - 22,727 70,322 Convertible Note Payable - LGC (8%) BEN 46,803 - (27,689 ) - 19,114 65,114 Convertible Note Payable - LGC (8%) 50,000 - (35,841 ) - 14,159 69,145 Convertible Note Payable - CB (5%) (Original $35k) - - - - - 1,210 Convertible Note Payable - LGC (8%) 25,000 (5,399 ) - - 19,601 19,807 Convertible Notes Payable - VV to LG (8%) #1 - - 1,358 - 1,358 - Convertible Notes Payable - VV (8%) #2 38,000 - - (680 ) 37,320 - Convertible Notes Payable - SO-B (8%) (Original $60k) 22,421 - - - 22,421 56,156 Convertible Notes Payable - SO (8%) 57,750 (3,092 ) - (2,932 ) 51,726 - $ 440,949 $ (8,491 ) $ (129,473 ) $ (9,055 ) $ 293,930 $ 363,977 As of September 30, 2016, the convertible notes payable can be converted into approximately 97,120,990 shares of common stock.

Derivatives and Fair Value Inst

Derivatives and Fair Value Instruments	9 Months Ended
	Sep. 30, 2016
Derivatives and Fair Value Instruments [Abstract]
DERIVATIVES AND FAIR VALUE INSTRUMENTS	Note 6. DERIVATIVES AND FAIR VALUE INSTRUMENTS The Company applied paragraph 815-10-05-4 of the FASB Accounting Standards Codification to the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016. Based on the guidance in paragraph 815-10-05-4 of the FASB Accounting Standards Codification the Company concluded these instruments were required to be accounted for as derivatives on issuance date. The Company records the fair value of the Convertible Notes Payable and certain warrants that are classified as derivatives on issuance date and the fair value changes on each reporting date reflected in the consolidated statements of operations as “Gain (loss) on derivative liabilities.” These derivative instruments are not designated as hedging instruments under paragraph 815-10-05-4 of the FASB Accounting Standards Codification and are disclosed on the balance sheet under Derivative Liabilities. The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below: Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepayments and other current assets, accounts payable, and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s Level 3 financial liabilities consist of the 5% Convertible Notes Payable issued June 12th 2015 and the 8% Convertible Note payable issued June 25th 2015 and for the 8% Convertible Notes Payable issued January 7, 2016 and March 7, 2016, for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. We have valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a valuation consultant, for which management understands the methodologies. These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of issuance and September 30, 2016. The primary assumptions include: projected annual volatility of 98%-220%; the follow-on securities purchase option; the conversion feature as a percentage of Market; automatic/conditional conversions; market price trigger events. As of September 30, 2016 the Company’s derivative financial instruments included: 1) Embedded derivatives associated with certain of the Company’s unsecured convertible notes payable. The Company’s 5 % convertible notes payable and 8% convertible notes payable issued to four unrelated investors is a hybrid instrument, which warrants separate accounting as a derivative instrument. The embedded derivative feature has been bifurcated from the debt host contract, referred to as the Derivative Liability, which resulted in a reduction of the initial carrying amount (as unamortized discount) of the Convertible Notes Payable. The unamortized discount is amortized to interest expense using the effective interest method over the life of the Notes. The embedded derivative feature includes the conversion feature within the notes and an early redemption option. The compound embedded derivatives within the convertible notes have been recorded at fair value at the date of issuance; and are marked-to-market each reporting period with changes in fair value recorded to the Company’s statement of operations as Change in fair value of derivative liabilities. The 5% Convertible Note Payable and the 8% Convertible Notes Payable are valued at September 30, 2016. The following assumptions were used for the valuation of the embedded derivative: - The stock price of $0.0071 up to $0.0152 and back down to $.0073 in this period (variable conversion price) would fluctuate with the Company projected volatility; - An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%; - Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%; - Capital raising events (a single financing at 1 month from the valuation date) are a factor for the VV to LG Convertible Note. The full reset events projected to occur based on future stock issuance (single event) resulting in a reset exercise price. - The monthly trading volume would average $126,178 and would increase at 5% per month;ownership limits conversion across LG’s 6 notes based on 4.99% with shares outstanding increasing monthly by 1%. - The variable conversion price of 50% to 58% over 3 to 20 trading days would have effective rates of 43.09% to 51.81%; - The Note Holders would automatically convert the notes early (and not hold to maturity) with variable conversion prices and full ratchet resets if the registration was effective and not in default; - The projected annual volatility for each valuation period was based on the historical volatility of the company: 6/30/2016 172% 7/25/2016 212% 7/12/2016 213% 7/28/2016 212% 7/15/2016 217% 8/19/2016 184% 7/18/2016 203% 9/13/2016 172% 7/16/2016 220% 9/21/2016 98% 7/20/2016 215% 9/30/2016 128% The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuation. The Company’s convertible notes payable and the related derivative liabilities, derivative discount and original-issue discount are presented in the financial statements at September 30, 2016 as follows: Quarter Quarter Quarter Quarter Ended Quarter Quarter Ended Quarter Quarter Ended Derivative Ended March 31, Derivative Ended Ended June 30, Derivative Ended Ended Sept. 30, Derivative Derivative Maturity Principal Original Valuation December 31, March 31, 2016 Valuation June 30, June 30, 2016 Valuation Sept. 30, Sept. 30, 2016 Valuation Sept. 30, Convertible Note Date Date Amount Valuation 2015 Conversions Market 2016 Conversions Issuances Market 2016 Conversions Issuances Market 2016 8% Convertible Note Payable - issued 10/8/2015 10/8/2015 10/8/2015 $ 31,000 $ 58,779 $ 56,366 - $ (4,203 ) $ 52,163 - - $ (20,977 ) $ 31,186 $ (7,521 ) - $ (3,858 ) $ 19,807 5 % Convertible Note- Payable - issued 6/12/2015 12/9/2015 12/12/2015 100,000 37,827 35,176 - (2,883 ) 32,293 (11,835 ) 9,106 29,564 (24,318 ) - 50,910 56,156 8% Convertible Notes Payable - issued 6/25/2015 12/22/2015 1/7/2017 59,000 56,956 66,075 $ (10,151 ) 3,285 59,209 (8,604 ) (9,573 ) 41,032 (46,218 ) - 5,186 - 8% Convertible Notes Payable - issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 - - 39,919 127,206 (58,513 ) 68,693 - 15,936 84,629 8% Convertible Notes Payable - issued January 7, 2016 1/7/2016 1/7/2017 50,000 68,124 - - 21,773 89,897 (35,511 ) 54,386 - 13,530 67,916 8% Convertible Notes Payable - issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 - - 1,171 88,709 (34,869 ) 53,840 - 15,305 69,145 8% Convertible Notes Payable - issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 - - 1,101 83,216 (32,498 ) 50,718 - 14,396 65,114 8% Convertible Notes Payable - issued March 7, 2016 4/12/2016 1/7/2017 35,863 - - - - (21,595 ) 64,124 (21,304 ) 21,225 (21,330 ) - 1,315 1,210 $ 477,666 $ 478,626 $ 157,617 $ (10,151 ) $ 60,163 $ 532,693 $ (42,034 ) $ 64,124 $ (204,139 ) $ 350,644 $ (99,387 ) $ - $ 112,720 $ 363,977 The Company's total mark-to-market fair value adjustment ((income)/expense) for the nine months ended September 30, 2016 amounted to ($31,256) as follows: Mark-to market fair value adjustment for the quarter ended March 31, 2016 $ 60,163 Mark-to market fair value adjustment for the quarter ended June 30, 2016 (204,139 ) Mark-to market fair value adjustment for the quarter ended September 30, 2016 112,720 Total mark-to market fair value adjustment for the nine months ended September 30, 2016 $ (31,256 )

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2016
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	Note 7. STOCKHOLDERS' EQUITY The Company has authorized 1,500,000,000 shares of common stock with a par value of $0.0001 per share. There were 110,366,413 and 35,101,750 shares of common stock issued and outstanding at September 30, 2016 and December 31, 2015, respectively. The Company has authorized 1,000,000 shares of Series A preferred stock with a par value of $0.0001 per share. At September 30, 2016 and December 31, 2015, 50,000 shares of Series A preferred stock were issued and outstanding. The preferred stock has preferential voting rights of 100 votes per outstanding share. The Company has authorized 50,000 shares of Series B convertible preferred stock with a par value of $0.0001 per share. At September 30, 2016 there were 39,000 shares issued of which 12,900 shares of Series B preferred were converted into common stock in accordance with the terms of the Series B Preferred stock. Therefore; there were 26,100 shares outstanding at September 30, 2016. The Series B preferred stock has no voting rights. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock. During the quarter ended March 31, 2015, the Company issued 2,000,000 shares of common stock at $0.001 per share as partial conversion of notes. During the quarter ended March 31, 2015, the Company issued 800,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended March 31, 2015, a stockholder of the Company returned 500,000 shares of common stock to the Company. During the quarter ended June 30, 2015, the Company issued 2,300,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended September 30, 2015, the Company issued 3,800,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended September 30, 2015, the Company issued 20,000 shares of common stock at $0.015 per share as to acquire 100% of the outstanding shares of the Company's subsidiary. During the quarter ended September 30, 2015, the Company issued 3,000,000 shares of common stock at $0.01 per share as Officer's compensation. During the quarter ended September 30, 2015, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended December 31, 2015, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended December 31, 2015, the Company issued 200,000 shares of common stock at $0.01 per share to an investor. During the quarter ended March 31, 2016, the Company issued 1,095,036 shares of common stock at $0.00275 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,285,560 shares of common stock at $0.00275 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 906,533 shares of common stock at $0.003355 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,500,000 shares of common stock at $0.00275 per share as partial conversion of notes. During the quarter ended March 31, 2016, the Company issued 1,700,000 shares of common stock upon conversion of 3,400 shares of Series B preferred stock. During the quarter ended March 31, 2016, the Company issued 10,000 shares of Series B Preferred stock in settlement of the $50,000 liability to a related party for the purchase of inventory. During the quarter ended June 30, 2016, the Company issued 1,584,873 shares of common stock at $0.0033 per share as partial conversion of notes. During the quarter ended June 30, 2016, the Company issued 2,194,200 shares of common stock at $0.0033 per share as partial conversion of notes. During the quarter ended June 30, 2016, the Company issued 2,000,000 shares of common stock at $0.0044 per share as partial conversion of notes. During the quarter ended June 30, 2016, the Company issued 2,500,000 shares of common stock at $0.0029 per share as partial conversion of notes. During the quarter ended June 30, 2016, the Company issued 783,062 shares of common stock at $0.0038 per share as partial conversion of notes. During the quarter ended June 30, 2016, the Company issued 768,026 shares of common stock at $0.0036 per share as partial conversion of notes. During the quarter ended June 30, 2016, the Company issued 853,643 shares of common stock at $0.0028 per share as partial conversion of notes. During the quarter ended June 30, 2016 the Company amended a Convertible Debenture originally issued June 12, 2015. The Company issued 300,000 shares to the debenture holder for the main purpose of extending the maturity date to one year from the date of the amendment. During the quarter ended June 30, 2016, the Company issued 1,950,000 shares of common stock upon conversion of 3,900 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 1,100,000 shares of common stock upon conversion of 2,200 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 1,700,000 shares of common stock upon conversion of 3,400 shares of Series B preferred stock. During the quarter ended June 30, 2016, the Company issued 4,000 shares of Series B Preferred stock in settlement of the $20,000 liability to a related party for the purchase of a trademark. On April 15, 2016 the Company entered into a Business Consulting Agreement with a Michigan limited liability company ("Consultant"). The agreement provides for the Company retaining the Consultant for 125 days for general business and product development services. The Consultant shall be paid $750 per month in cash and 500,000 shares of common stock of the Company valued at $5,000 as of the effective date and another 500,000 common shares upon determination of the Company in its sole and absolut discretion. During the quarter ended June 30, 2016 pursuant to the Business Consulting Agreement, the Company issued 500,000 shares of common stock at $0.01 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued 1,356,747 shares of common stock at $0.002915 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,500,000 shares of common stock at $0.002915 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,213,714 shares of common stock at $0.0029 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 3,193,941 shares of common stock at $0.002915 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 3,180,000 shares of common stock at $0.002915 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 3,352,874 shares of common stock at $0.002915 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 1,194,500 shares of common stock at $0.002915 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 3,333,073 shares of common stock at $0.00352 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,693,624 shares of common stock at $0.0039 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,886,003 shares of common stock at $0.003465 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,995,816 shares of common stock at $0.0029 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,226,772 shares of common stock at $0.0029 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,400,000 shares of common stock at $0.0005 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 3,000,000 shares of common stock at $0.001 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 2,516,666 shares of common stock at $0.0028 per share as partial conversion of notes. During the quarter ended September 30, 2016, the Company issued 4,000,000 shares of common stock at $0.0092 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued 3,000,000 shares of common stock at $0.0083 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued 2,000,000 shares of common stock at $0.0083 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued 500,000 shares of common stock at $0.0078 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued 2,000,000 shares of common stock at $0.0065 per share for services provided to the Company. During the quarter ended September 30, 2016, the Company issued 2,000,000 shares of common stock at $0.0083 per share for services provided to the Company.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	Note 8. COMMITMENTS AND CONTINGENCIES The Company currently has three office locations. It rents offices on a month-to-month basis from the Company's President and stockholder for $525 per month which amounted to $1,575 for the quarter-ended September 30, 2016. The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment. The cost of this space for the quarter-ended September 30, 2016 was $347. On September 12th 2016 the Company entered into a commercial lease agreement for office premises at a cost of $650 per month for a one-year term with the option to renew for one extended term of three years. The cost of this space for the quarter ended September 30, 2016 was $325. The Company has agreements with consultants for ongoing services to be rendered with the following commitments: Commitment Term Consultant - FDA requirements and compliance $2000 per month 12 Months Consultant - capital formation and market services Various equity percentage issuances of restricted stock for fundings 6 Months Consultant - tradeshow attendence, strategy and collaboration, cordination regarding FDA compliance, manuafacturing operations, sales and marketing, other related services $10,000 per month (payable quarterly in cash or common stock from the 2016 Equity Incentive Plan) 12 Months

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2016
Income Taxes [Abstract]
INCOME TAXES	Note 9. INCOME TAXES The Company's deferred tax asset consists primarily of carryforward net operating losses (NOLs). The Company believes that, at this time, it is more likely than not that the benefit of the NOLs will not be realized and has therefore recorded a full valuation allowance. The income tax benefit differs from the amount computed by applying the statutory federal and state income tax rates to the loss before income taxes. The sources and tax effects of the differences are as follows: September 30, 2016 December 31, 2015 Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 % As of September 30, 2016, the Company has a net operating loss carryforward of approximately $1,553,512 to reduce future federal taxable income which begins to expire in the year 2030. The Company is also subject to corporate taxes in the State of New Jersey which has similiar net operating loss carryover provisions which start to expire in the year 2030. The Company currently has no federal or state tax examinations in progress, nor has it had any federal or state examinations since its inception. All of the Company's open tax years beginning in tax year 2013 are subject to federal and state tax examinations.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	Note 10. RELATED PARTY TRANSACTIONS In August 2015, the Company acquired 100% of the issued and outstanding common stock of Medical Lasers Manufacturer, Inc. ("MLM") from a stockholder and officer of the Company for 20,000 common shares which were valued at $0.015 per share. All intercompany transactions were eliminated during consolidation. As more fully described in Note 3 to the Consolidated Financial Statements, the Company owed the following amounts to related parties as of September 30: 2016 2015 Due to Related Party $ 8,921 $ 8,921 Due to Officer/Stockholder 8,446 8,446 Due to other Stockholders 4,090 49,300 Total Related Party Obligations $ 21,457 $ 66,667 The company has entered into an employment agreement with its Chief Executive Officer (CEO) for the five year period beginning January 1, 2012. The agreement provides for base compensation, annual bonus, benefits, vacation and reimbursements. Under this agreement, the base compensation of the Company's CEO is $100,000 per annum which has been accrued for the years ended December 13, 2015 and 2014. During the quarter ended June 30, 2016 the Company commenced payroll and is paying the CEO for current wages in this manner. For the quarter ended September 30, 2016 the CEO was paid $15,000 via payroll and $10,000 was accrued. For the nine months ended September 30, 2016, $18,974 in accrued compensation was paid. Accrued compensation in the amount of $30,000 was converted to shares of common stock during 2015. In August 2015, MLM acquired a trademark from the son of the Company’s President for $20,000 due 90 days from the date of acquisition. During the quarter ended June 30, 2016, the Company issued 3,400 shares of Preferred Series B stock as settlement on this liability. Due to the uncertainty of future cash flows from the trademark management has deemed it to be impaired and recorded an impairment expense of $20,000 at September 30, 2015. In August 2015, subsequent to the date the Company acquired MLM, MLM purchased $50,000 in inventory from the son of the Company's President. The inventory consisted of 20 hand-held laser devices. During the quarter-ended March 31, 2016, 10,000 shares of Series B Preferred stock were issued in settlement of this liability. As more fully described in Note 1-Intangible Asset-Licensing Agreement, on March 8th 2016 the Company entered into a Licensing Agreement with a Florida Corporation (Licensor) that is owned by a related party. The Company issued 25,000 shares of Series B Preferred stock to the Licensor as partial consideration for the Licensing agreement plus a $150,000 promissory note to the Licensor for the balance of the consideration. During the quarter-ended March 31, 2016, 3,400 shares of Series B Preferred stock were converted into 1,700,000 shares of common stock in accordance with the terms of the Series B Preferred stock.

Basis of Reporting - Going Conc

Basis of Reporting - Going Concern	9 Months Ended
	Sep. 30, 2016
Basis of Reporting - Going Concern [Abstract]
BASIS OF REPORTING - GOING CONCERN	Note 11. BASIS OF REPORTING - GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $1,779,549, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon management's plans to raise additional capital from the sale of stock and receive additional loans from related parties. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Stock Compensation - Equity Inc

Stock Compensation - Equity Incentive Plan	9 Months Ended
	Sep. 30, 2016
Stock Compensation - Equity Incentive Plan [Abstract]
STOCK COMPENSATION - EQUITY INCENTIVE PLAN	Note 12. STOCK COMPENSATION - EQUITY INCENTIVE PLAN In July 2016, the Company adopted the Medifirst Solutions, Inc. 2016 Equity Incentive Plan (the "Plan”) pursuant to which the Company may grant stock options, restricted stock purchase offers and other equity-based awards up to an aggregate of 20,000,000 shares of common stock. The Plan is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company. During the quarter ended September 30, 2016, the Company issued from the Plan a total of 8,000,000 shares of common stock to non-employees for services rendered. As of September 30, 2016 there is a balance of 12,000,000 shares available for future issuance under the Medifirst Solutions, Inc. 2016 Equity Incentive Plan.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2016
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	Note 13. SUBSEQUENT EVENTS On October 1, 2016 the Company entered into an Independent Sales Representative Agreement with an individual whose primary duty will consist of soliciting orders for the Company's product in specific territories. The agreement defines prices, terms of sale, base compensation, accepted orders, and reimbursement of expenses. The agreement is for a term of 12 months. On October 6, 2016 a noteholder elected to partially convert $12,500 of outstanding principal on a convertible note payable into 3,696,081 shares of common stock. The principal balance due remaining under the note payable after the conversion is $12,500. On October 11, 2016 in a private transaction, the holder of a $3,000 promissory note originally issued by the Company on April 10th 2015 and bearing 8% interest, sold it to another individual. On October 11, 2016, the Company issued to an Investor a replacement convertible note in the principal amount of $50,000 ("the Replacement Note"). The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum. This Replacement Note partially replaces a note originally issued on June 12, 2015 in the principal amount of $100,000. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion. Any unamortized original issue discount and deferred financing costs from the original note will be expensed upon replacement. The derivative discount and liability on the original note will be appropriately accounted for upon replacement and a new derivative discount and liability for the replacement note appropriately recorded. On October 11, 2016, the Company issued to an Investor a convertible note in the principal amount of $157,895 ("the Note"). The Note, which matures on March 27, 2018, pays interest at the rate of 9% per annum. The note contains an original issue discount in the amount of $7,895. The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 57.5% of the lowest trading price for the twenty prior trading days including the date of conversion. On October 12th, 2016, the Company issued 2,000,000 shares of common stock under the 2016 Incentive Stock Plan as payment to an individual consultant in settlement of services rendered in the amount of approximately $10,000 (including monthly fees through October 31, 2016). On October 12, 2016 the Company entered into a Consulting Agreement with an individual who will provide a variety of business development services. The term of the agreement commences October 15th 2016 and continues until terminated. Compensation under the agreement is for 2,000,000 shares of restricted common stock, 1,250,000 shares of Consulting Warrants exercisable for 18 months at an exercise price of $0.02 and $3,000 per month payable, at the Company's discretion, in cash or S-8 shares, which will be priced no greater than 80% of the prior day closing price. Pursuant to the terms of the agreement, 2,000,000 restricted shares of common stock were issued to the consultant on October 21, 2016. On October 13, 2016 a noteholder elected to partially convert $12,500 of outstanding principal balance on a convertible note payable into 5,000,000 shares of common stock. The principal balance due remaining under the note payable after the conversion is $37,500. On November 6, 2016 a noteholder elected to convert $12,500 of outstanding principal and $1,068 of accrued interest on a convertible note payable into 5,705,841 shares of common stock. There is no principal balance due under the note payable after this conversion. On November 8th, 2016, the Company issued 3,500,000 shares of restricted common stock as payment to an individual consultant for services. On November 8, 2016 a noteholder elected to partially convert $11,500 of outstanding principal balance on a convertible note payable into 5,750,000 shares of common stock. The principal balance due remaining under the note payable after the conversion is $26,000.

Nature of Operations and Summ21

Nature of Operations and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Nature of Operations and Summary of Significant Accounting Policies [Abstract]
Organization	Organization Medifirst Solutions, Inc. ("MSI" or the "Company") was incorporated in Nevada in November 2010. The Company has not generated significant sales to date. The Company intends to have a diverse product line of consumer products. Since inception, the Company has been engaged in business planning activities, including researching the industry, identifying target markets for the Company's products, developing the Company's models and financial forecasts, performing due diligence regarding potential geographic locations most suitable for establishing the Company's offices and identifying future sources of capital. At the present time, the Company is building products and affiliations in and related to the cosmetic healthcare industry. In July 2016, Medifirst, in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device.The Company is actively putting together a sales and distribution team to offer our lasers in the US market. Pursuant to a sale and purchase agreement dated August 19, 2015 between the Company and the Company's president, the Company acquired 100% of the equity interests in Medical Lasers Manufacturer, Inc. ("MLM") with the total purchase price of 20,000 shares of the Company's common stock at $0.001 per share (or $20). The fair value of the acquired entity was $20. The transaction was considered as a business acquisition and accordingly the acquisition method of accounting has been applied. MLM had no assets at the date of the business combination. The Consolidated financial statements include the accounts of MSI and its only wholly owned subsidiary, MLM. All material intercompany balances and transactions have been eliminated in consolidation. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to operationalize the Company’s current technology.
Basis of Presentation	Basis of Presentation The accompanying unaudited financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such principles and regulations of the Securities and Exchange Commission for Form 10-Q. All adjustments, consisting of normal recurring adjustments, have been made which, in the opinion of management, are necessary for a fair presentation of the results of interim periods. The results of operations for such interim periods are not necessarily indicative of the results that may be expected for a full year because of, among other things, seasonality factors in the retail business. The unaudited financial statements contained herein should be read in conjunction with the audited financial statements and notes thereto for the fiscal year ended December 31, 2015. Some items in the prior year financial statements were reclassified to conform to the current presentation. Reclassifications had no effect on prior year net income or shareholders’ equity.
Revenue Recognition	Revenue Recognition In general, the Company records revenue when persuasive evidence of an arrangement exists, services have been rendered or product delivery has occurred, the sales price to the customer is fixed or determinable, and collectability is reasonably assured. The following policies reflect specific criteria for the various revenues streams of the Company: Revenue is recognized at the time the product is delivered or services are performed. Provision for sales returns are estimated based on the Company's historical return experience. Revenue is presented net of returns.
Accounts Receivable	Accounts Receivable The Company extends credit to its customers in the normal course of business and performs ongoing credit evaluations of its customers, maintaining an allowance for potential credit losses. Accounts receivable is reported net of the allowance for doubtful accounts. The allowance is based on management's estimate of the amount of receivables that will actually be collected. The Company has not recorded an allowance for doubtful accounts as of September 30, 2016 or December 31, 2015.
Inventory	Inventory Inventory consists of finished goods and is stated at the lower of cost (first-in, first-out) or market value.
Equipment	Equipment Equipment, consisting of computer equipment, is stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, of five years.
Long-Lived Assets	Long-Lived Assets The Company reviews long-lived assets, such as equipment, for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds the estimated future cash flows, an impairment loss will be recorded by the amount the carrying value exceeds the fair value of the asset. In August 2015, the Company's wholly-owned subsidiary MLM, acquired a trademark for $20,000. Due to the uncertainty of future cash flows from the trademark, management has deemed it to be impaired and recorded an impairment expense of $20,000 in the quarter ended September 2015.
Intangible Asset- Licensing Agreement	Intangible Asset- Licensing Agreement On March 8th 2016, the company, through it's sole wholly-owned subsidiary ("Licensee"), entered into a Product and Know-How License Agreement ("Agreement") with a Florida Corporation ("Licensor"). The license provides with respect to the Technology, Licensor hereby grants to Licensee an irrevocable, nontransferable, royalty-bearing license, with a right of sublicense (the “License”), throughout the Territory in the Field of Use, whether or not under the Licensed Patent, to: - use or submit or deliver the Technology and/or any Product to any regulatory body throughout the Territory for purposes of obtaining approval to make, Sell, offer for Sale, import, export and distribute the Technology or Products; and - use or copy the Technology and/or any Product; and - market, make, have made, Sell, offer for Sale, import and distribute Products; and - sublicense the Technology; and - prepare, or have prepared on its behalf, modifications, enhancements and/or derivative works of the Technology. In connection with the license granted, Licensor hereby grants to Licensee a license to the Licensed Patents, whether now existing or hereafter acquired. The consideration for the licensing agreement consisted of the issuance of 25,000 Series B Preferred stock shares to the Licensor (at par) plus a $150,000 promissory note issued by the Company to the licensor. The last part of the consideration in this license agreement is the royalty payments which have not taken effect yet as they are based on sales for which the company has none. The licensing agreement is for a ten year period effective from March 8th 2016. The cost of the licensing agreement is being amortized over it's ten-year period and charged to income on a straight-line basis.
Debt Issues Costs and Debt Discount	Debt Issues Costs and Debt Discount The Company may pay debt issue costs, and record debt discounts in connection with raising funds through the issuance of convertible debt. These costs are amortized over the life of the debt to interest expense. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts are immediately expensed. Beginning in 2015, the Company early-adopted ASU 2015-03: Simplifying the Presentation of Debt Issuance Costs and has reflected the deferred financing costs as a direct reduction of the related debt (See table included in Note 5 to Consolidated Financial Statements).
Original Issue Discount	Original Issue Discount For certain convertible debt issued, the Company provides the debt holder with an original issue discount. The original issue discount is recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.
Derivative Liabilities	Derivative Liabilities Fair value accounting requires bifurcation of embedded derivative instruments such as conversion features in convertible debt or equity instruments, and measurement of their fair value for accounting purposes. The Company assessed its securities for purposes of determining the proper accounting treatment and valuation as set forth in the Statement of Financial Accounting Standard ASC 820–10–35–37 Fair Value in Financial Instruments Accounting for Derivative Instruments and Hedging Activities In assessing the convertible debt instruments, management determines if the convertible debt host instrument is conventional convertible debt and further if there is a beneficial conversion feature requiring measurement. If the instrument is not considered conventional convertible debt, the Company will continue its evaluation process of these instruments as derivative financial instruments. Once the derivative liabilities are determined, they are adjusted to reflect fair value at each reporting period end, with any increase or decrease in the fair value being recorded in results of operations as an adjustment to fair value of derivatives.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated balance sheets and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Financial Instruments	Financial Instruments The carrying amounts reported in the balance sheets for cash, accounts receivable, accounts payable, and other accrued liabilities approximate their fair values.
Segment Information	Segment Information The Company follows Accounting Standards Codification ("ASC") 280, "Segment Reporting". The Company currently operates in a single segment and will evaluate additional segment disclosure requirements as it expands its operations.
Net Income (Loss) Per Common Share	Net Income (Loss) Per Common Share The Company calculates net income (loss) per share based on the authoritative guidance. Basic earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares and dilutive common stock equivalents outstanding. During periods in which the Company incurs losses, common stock equivalents, if any, are not considered, as their effect would be anti-dilutive.
Income Taxes	Income Taxes The Company utilizes the accrual method of accounting for income taxes. Under the accrual method, deferred tax assets and liabilities are determined based on the differences between the financial reporting basis and the tax basis of the assets and liabilities, and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. An allowance against deferred tax assets is recognized, when it is more likely than not, that such tax benefits will not be realized. The Company recognizes the financial statement benefit of an uncertain tax position only after considering the probability that a tax authority would sustain the position in an examination. For tax positions meeting a “more-likely-than-not” threshold, the amount recognized in the financial statements is the benefit expected to be realized upon settlement with the tax authority. For tax positions not meeting the threshold, no financial statement benefit is recognized. The Company recognizes interest and penalties, if any, related to uncertain tax positions in income tax expense. The Company did not have any unrecognized tax benefits as of September 30, 2016, and does not expect this to change significantly over the next 12 months.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees in accordance with ASC 718, Compensation - Stock Compensation. ASC 718 requires all share-based compensation payments to be recognized in the financial statements based on the fair value on the issuance date. Equity instruments granted to non-employees are accounted for in accordance with ASC 505, Equity. The final measurement date for the fair value of equity instruments with performance criteria is the date that each performance commitment for such equity instrument is satisfied or there is a significant disincentive for non-performance.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At September 30, 2016, the Company had $134,079 in cash equivalents and $156,958 in cash equivalents a December 31, 2015.
Recent Pronouncements	Recent Pronouncements In May 2014, FASB and IASB issued a new joint revenue recognition standard that supersedes nearly all GAAP guidance on revenue recognition. The core principle of the standard is that revenue recognition should depict the transfer of goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard is effective for the Company for the fiscal year beginning June 1, 2017. The Company is currently evaluating the impact of this ASU on the consolidated financial statements. On January 05, 2016, the FASB completed its Classification and Measurement of Financial Instruments project by issuing ASU No. 2016-01, Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance improves certain aspects of recognition, measurement, presentation and disclosure of financial instruments. For public business entities, the new guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In November 2015, FASB issued ASU 2015-17 - Income Taxes (Topic 740) Balance Sheet Classification of Deferred Taxes which simplifies the presentation of deferred income taxes. For public business entities, the amendments in this Update are effective for financial statements issued for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material. In February 2015, FASB issued ASU 2015-02 Consolidation (Topic 810) Amendments to the Consolidation Analysis. The amendments in this Update affect reporting entities that are required to evaluate whether they should consolidate certain legal entities. All legal entities are subject to reevaluation under the revised consolidation model. The amendments in this Update are effective for public business entities for fiscal years, and for interim periods within those fiscal years, beginning after December 15, 2015. The Company does not believe the impact of its pending adoption of this ASU on the Company’s consolidated financial statements will be material.

Property, Plant and Equipment22

Property, Plant and Equipment (Net)(Tables)	9 Months Ended
	Sep. 30, 2016
Property, Plant and Equipment (Net) [Abstract]
Summary of equipment recorded at cost	2016 2015 Computer equipment $ 8,314 $ 8,314 Less: accumulated depreciation (6,925 ) (6,155 ) $ 1,389 $ 2,159

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2016
Short-term Debt [Line Items]
Schedule of derivative liabilities	Remaining Original Deferred Total Convertible Principal Issue Derivative Financing Notes Derivative Debt Amount Discount Discount Costs Payable Liability Note Payable - BS $ 125 - - - $ 125 - Note Payable - SF 60 - - - 60 - Note Payable - MC #1 2,075 - - - 2,075 - Note Payable - NW 715 - - - 715 - Note Payable - MC #2 3,000 - - - 3,000 - Debenture Payable (5%) - B (Original $100K) 40,000 - - (30 ) 39,970 - Convertible Note Payable - LGC (8%) 105,000 - (40,028 ) (5,414 ) 59,558 82,223 Convertible Note Payable - LGC (8%) BEN 50,000 - (27,273 ) - 22,727 70,322 Convertible Note Payable - LGC (8%) BEN 46,803 - (27,689 ) - 19,114 65,114 Convertible Note Payable - LGC (8%) 50,000 - (35,841 ) - 14,159 69,145 Convertible Note Payable - CB (5%) (Original $35k) - - - - - 1,210 Convertible Note Payable - LGC (8%) 25,000 (5,399 ) - - 19,601 19,807 Convertible Notes Payable - VV to LG (8%) #1 - - 1,358 - 1,358 - Convertible Notes Payable - VV (8%) #2 38,000 - - (680 ) 37,320 - Convertible Notes Payable - SO-B (8%) (Original $60k) 22,421 - - - 22,421 56,156 Convertible Notes Payable - SO (8%) 57,750 (3,092 ) - (2,932 ) 51,726 - $ 440,949 $ (8,491 ) $ (129,473 ) $ (9,055 ) $ 293,930 $ 363,977
Converted note 110 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Principal Date of Conversion Amount Converted Conversion Shares June 2013 $ 70 $ 0.0001 700,000 August 2013 $ 40 $ 0.0001 400,000
Converted note additional 90 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Principal Date of Conversion Amount Converted Conversion Shares November 2013 $ 40 $ 0.0001 400,000 December 2013 $ 50 $ 0.0001 500,000
Converted note additional 90 one [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Principal Date of Conversion Amount Converted Conversion Shares March 2014 $ 5 0 $ 0.0001 500,000 April 2014 $ 40 $ 0.0001 400,000
Converted note 1,010 [Member]
Short-term Debt [Line Items]
Schedule of convertible note conversion detail	Principal Date of Conversion Amount Converted Conversion Shares December 2012 $ 150 $ 0.001 $ 150,000 January 2013 $ 660 $ 0.001 $ 660,000 March 2013 $ 200 $ 0.001 $ 200,000

Derivatives and Fair Value In24

Derivatives and Fair Value Instruments (Tables)	9 Months Ended
	Sep. 30, 2016
Derivatives and Fair Value Instruments [Abstract]
Summary of projected annual volatility for each valuation period	6/30/2016 172% 7/25/2016 212% 7/12/2016 213% 7/28/2016 212% 7/15/2016 217% 8/19/2016 184% 7/18/2016 203% 9/13/2016 172% 7/16/2016 220% 9/21/2016 98% 7/20/2016 215% 9/30/2016 128%
Summary of convertible notes payable	Quarter Quarter Quarter Quarter Ended Quarter Quarter Ended Quarter Quarter Ended Derivative Ended March 31, Derivative Ended Ended June 30, Derivative Ended Ended Sept. 30, Derivative Derivative Maturity Principal Original Valuation December 31, March 31, 2016 Valuation June 30, June 30, 2016 Valuation Sept. 30, Sept. 30, 2016 Valuation Sept. 30, Convertible Note Date Date Amount Valuation 2015 Conversions Market 2016 Conversions Issuances Market 2016 Conversions Issuances Market 2016 8% Convertible Note Payable - issued 10/8/2015 10/8/2015 10/8/2015 $ 31,000 $ 58,779 $ 56,366 - $ (4,203 ) $ 52,163 - - $ (20,977 ) $ 31,186 $ (7,521 ) - $ (3,858 ) $ 19,807 5 % Convertible Note- Payable - issued 6/12/2015 12/9/2015 12/12/2015 100,000 37,827 35,176 - (2,883 ) 32,293 (11,835 ) 9,106 29,564 (24,318 ) - 50,910 56,156 8% Convertible Notes Payable - issued 6/25/2015 12/22/2015 1/7/2017 59,000 56,956 66,075 $ (10,151 ) 3,285 59,209 (8,604 ) (9,573 ) 41,032 (46,218 ) - 5,186 - 8% Convertible Notes Payable - issued January 7, 2016 1/7/2016 1/7/2017 105,000 87,287 - - 39,919 127,206 (58,513 ) 68,693 - 15,936 84,629 8% Convertible Notes Payable - issued January 7, 2016 1/7/2016 1/7/2017 50,000 68,124 - - 21,773 89,897 (35,511 ) 54,386 - 13,530 67,916 8% Convertible Notes Payable - issued March 7, 2016 3/7/2016 3/7/2017 50,000 87,538 - - 1,171 88,709 (34,869 ) 53,840 - 15,305 69,145 8% Convertible Notes Payable - issued March 7, 2016 3/7/2016 1/7/2017 46,803 82,115 - - 1,101 83,216 (32,498 ) 50,718 - 14,396 65,114 8% Convertible Notes Payable - issued March 7, 2016 4/12/2016 1/7/2017 35,863 - - - - (21,595 ) 64,124 (21,304 ) 21,225 (21,330 ) - 1,315 1,210 $ 477,666 $ 478,626 $ 157,617 $ (10,151 ) $ 60,163 $ 532,693 $ (42,034 ) $ 64,124 $ (204,139 ) $ 350,644 $ (99,387 ) $ - $ 112,720 $ 363,977
Summaryf of market fair value adjustment	Mark-to market fair value adjustment for the quarter ended March 31, 2016 $ 60,163 Mark-to market fair value adjustment for the quarter ended June 30, 2016 (204,139 ) Mark-to market fair value adjustment for the quarter ended September 30, 2016 112,720 Total mark-to market fair value adjustment for the nine months ended September 30, 2016 $ (31,256 )

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2016
Commitments and Contingencies [Abstract]
Schedule of consultants for ongoing services for commitment	Commitment Term Consultant - FDA requirements and compliance $2000 per month 12 Months Consultant - capital formation and market services Various equity percentage issuances of restricted stock for fundings 6 Months Consultant - tradeshow attendence, strategy and collaboration, cordination regarding FDA compliance, manuafacturing operations, sales and marketing, other related services $10,000 per month (payable quarterly in cash or common stock from the 2016 Equity Incentive Plan) 12 Months

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2016
Income Taxes [Abstract]
Schedule of statutory federal and state income tax rates to the loss before income taxes	September 30, 2016 December 31, 2015 Statutory federal income tax rate 34 % 34 % State income taxes, net of federal taxes 9 % 9 % Valuation allowance (43 )% (43 )% Effective income tax rate 0 % 0 %

Related Party Transactions (Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2016
Related Party Transactions [Abstract]
Summary of owed amounts to related parties	2016 2015 Due to Related Party $ 8,921 $ 8,921 Due to Officer/Stockholder 8,446 8,446 Due to other Stockholders 4,090 49,300 Total Related Party Obligations $ 21,457 $ 66,667

Nature of Operations and Summ28

Nature of Operations and Summary of Significant Accounting Policies (Details)

1 Months Ended

3 Months Ended

9 Months Ended

Sep. 30, 2015USD ($)

Aug. 19, 2015USD ($)$ / sharesshares

Sep. 30, 2016USD ($)

Sep. 30, 2015USD ($)

Sep. 30, 2016USD ($)Segmentshares

Sep. 30, 2015USD ($)

May 02, 2016USD ($)

Mar. 07, 2016

Feb. 29, 2016USD ($)

Jan. 13, 2016USD ($)

Jan. 07, 2016

Dec. 31, 2015USD ($)

Dec. 31, 2014USD ($)

Dec. 31, 2012

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Number of operating Segment | Segment

1

Cash equivalents

$ 143,352

$ 134,079

$ 143,352

$ 134,079

$ 143,352

$ 156,958

Estimated useful lives of the assets

Five years.

Impairment of trademark

20,000

$ 20,000

$ 20,000

Impairment expense

$ 20,000

Equity method investment, ownership percentage

100.00%

4.99%

4.99%

Fair value of acquired entity

$ 20

Total purchase price, Per share | $ / shares

$ 0.001

Convertible notes payable to investor, Face amount

477,666

Interest rate

8.00%

8.00%

Total purchase price | shares

20,000

Allowance for doubtful accounts

Series B Preferred Stock

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Issuance of Series B Preferred shares as part consideration for license agreement, shares | shares

25,000

Investor [Member]

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Convertible notes payable to investor, Face amount

$ 57,750

$ 50,000

Interest rate

8.00%

Promissory notes, Description

The two notes which were secured by fully collaterlized promissory notes receivable issued by the Investor to the Company in the total amount of $96,803 ($50,000 and $46,803 - also know as the "back-end notes") closed during the quarter ended June 30, 2016.

8 % Convertible Notes Payable One [Member]

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Convertible notes payable to investor, Face amount

50,000

$ 50,000

Promissory Note [Member]

Nature of Operations and Summary of Significant Accounting Policies (Textual)

Interest rate

6.00%

10.00%

Promissory note issued by company

$ 150,000

$ 150,000

$ 7,000

Property, Plant and Equipment29

Property, Plant and Equipment (Net) (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Property, Plant and Equipment (Net) [Abstract]
Computer equipment	$ 8,314	$ 8,314
Less: accumulated depreciation	(6,925)	(6,155)
Property, plant and equipment, net	$ 1,389	$ 2,159

Property, Plant and Equipment30

Property, Plant and Equipment (Net) (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Property Plant and Equipment (Net) (Textual)
Depreciation expense	$ 201	$ 416	$ 770	$ 1,247

Due to Related Party (Details)

Due to Related Party (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015
Due to Related Party (Textual)
Due to related party	$ 8,921	$ 8,921	$ 8,921

Loans Payable - Stockholders (D

Loans Payable - Stockholders (Details) - USD ($)	Jan. 07, 2016	Feb. 29, 2016	Jan. 31, 2016	Dec. 31, 2012	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Mar. 07, 2016
Loans payable stockholders (Textual)
Loans payable - stockholders					$ 10,936		$ 20,899
Shareholders advance					$ 0	$ 20,670
Interest rate on loan	8.00%								8.00%
Maturity date	Jan. 7, 2017				Jul. 2, 2012
Principal amount converted	$ 105,000		$ 251,803		$ 69,698
Loan balance					100	$ 100
Stockholder [Member]
Loans payable stockholders (Textual)
Shareholder indebted amount					$ 1,500		1,500
Interest rate on loan					26.70%
Maturity date					Jan. 1, 2014
Conversion Rate					$ 0.0001
Promissory Note [Member]
Loans payable stockholders (Textual)
Shareholder indebted amount				$ 5,000
Interest rate on loan		6.00%		10.00%
Maturity date		Feb. 4, 2017		Jun. 2, 2013
Principal amount converted							$ 2,400	$ 2,500
Shares issued on conversion of convertible notes							2,400,000	2,500,000
Note outstanding		$ 7,000
Promissory note issued by company		$ 7,000			$ 150,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Sep. 30, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803	$ 69,698
June 2013 [Member] | Converted note 110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 70
Conversion Rate			$ 0.0001
Shares Received			700,000
August 2013 [Member] | Converted note 110 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 40
Conversion Rate			$ 0.0001
Shares Received			400,000

Convertible Notes Payable (De34

Convertible Notes Payable (Details 1) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Sep. 30, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803	$ 69,698
November 2013 [Member] | Converted note additional 90 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 40
Conversion Rate			$ 0.0001
Shares Received			400,000
December 2013 [Member] | Converted note additional 90 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 50
Conversion Rate			$ 0.0001
Shares Received			500,000

Convertible Notes Payable (De35

Convertible Notes Payable (Details 2) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Sep. 30, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803	$ 69,698
March 2014 [Member] | Converted note additional 90 one [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 50
Conversion Rate			$ 0.0001
Shares Received			500,000
April 2014 [Member] | Converted note additional 90 one [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 40
Conversion Rate			$ 0.0001
Shares Received			400,000

Convertible Notes Payable (De36

Convertible Notes Payable (Details 3) - USD ($)	Jan. 07, 2016	Jan. 31, 2016	Sep. 30, 2016
Summary of convertible note conversion detail
Principal Amount Converted	$ 105,000	$ 251,803	$ 69,698
December 2012 [Member] | Converted note 1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 150
Conversion Rate			$ 0.001
Shares Received			150,000
January 2013 [Member] | Converted note 1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 660
Conversion Rate			$ 0.001
Shares Received			660,000
March 2013 [Member] | Converted note 1,010 [Member]
Summary of convertible note conversion detail
Principal Amount Converted			$ 200
Conversion Rate			$ 0.001
Shares Received			200,000

Convertible Notes Payables (Det

Convertible Notes Payables (Details 4) - USD ($)	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
Short-term Debt [Line Items]
Remaining Principal Amount				$ 477,666
Original Issue Discount	$ (8,491)
Derivative Discount	(129,473)
Deferred Financing Costs	(9,055)
Total Convertible Notes Payable	293,930			180,393
Derivative Liability	363,977	$ 350,644	$ 532,693	157,617
Note Payable - BS [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	125
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	125
Derivative Liability
Note Payable - SF [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	60
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	60
Derivative Liability
Note Payable - MC #1 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	2,075
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	2,075
Derivative Liability
Note Payable - NW [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	715
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	715
Derivative Liability
Note Payable - MC #2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	3,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	3,000
Derivative Liability
Debenture Payable (5%) - B (Original $100K) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	40,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs	(30)
Total Convertible Notes Payable	39,970
Derivative Liability
Convertible Note Payable - LGC (8%) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount				100,000
Original Issue Discount
Derivative Discount	(40,028)
Deferred Financing Costs	(5,414)
Total Convertible Notes Payable	59,558			100,000
Derivative Liability	56,156	29,564	32,293	35,176
Convertible Note Payable - LGC (8%) BEN [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	50,000
Original Issue Discount
Derivative Discount	(27,273)
Deferred Financing Costs
Total Convertible Notes Payable	22,727
Derivative Liability	70,322
Convertible Note Payable - LGC (8%) BEN 1 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount				31,000
Original Issue Discount
Derivative Discount	(27,689)
Deferred Financing Costs
Total Convertible Notes Payable	19,114			31,000
Derivative Liability	19,807	31,186	52,163	56,366
Convertible Note Payable - LGC (8%) 1 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount				59,000
Original Issue Discount
Derivative Discount	(35,841)
Deferred Financing Costs
Total Convertible Notes Payable	14,159			59,000
Derivative Liability		41,032	59,209	66,075
Convertible Note Payable - CB (5%) (Original $35k) [Member]
Short-term Debt [Line Items]
Remaining Principal Amount
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable
Derivative Liability	1,210
Convertible Note Payable - LGC (8%) 2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	25,000
Original Issue Discount	(5,399)
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	19,601
Derivative Liability	19,807
Convertible Notes Payable- VV to LG (8%) #1 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount
Original Issue Discount
Derivative Discount	1,358
Deferred Financing Costs
Total Convertible Notes Payable	1,358
Derivative Liability
Convertible Notes Payable- VV (8%) #2 [Member]
Short-term Debt [Line Items]
Remaining Principal Amount	38,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs	(680)
Total Convertible Notes Payable	37,320
Derivative Liability
Convertible Notes Payable- SO-B (8%) (Original $60k)
Short-term Debt [Line Items]
Remaining Principal Amount				50,000
Original Issue Discount
Derivative Discount
Deferred Financing Costs
Total Convertible Notes Payable	22,421
Derivative Liability	67,916	54,386	89,897
Convertible Notes Payable- SO (8%)
Short-term Debt [Line Items]
Remaining Principal Amount				50,000
Original Issue Discount	(3,092)
Derivative Discount
Deferred Financing Costs	(2,932)
Total Convertible Notes Payable	51,726
Derivative Liability	$ 69,145	$ 53,840	$ 88,709

Convertible Notes Payable (De38

Convertible Notes Payable (Details Textual 1) - USD ($)	Jan. 07, 2016	Jun. 30, 2014	Aug. 31, 2016	Jan. 31, 2016	Apr. 30, 2015	Oct. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Nov. 30, 2013	Oct. 31, 2013	Sep. 30, 2013	Aug. 31, 2013	Jul. 31, 2013	May 31, 2012	Mar. 31, 2011	Apr. 30, 2014	Sep. 30, 2016	Dec. 31, 2015	Mar. 07, 2016
Convertible Notes Payable (Textual)
Convertible notes payable to investor, Face amount																		$ 477,666
Principal amount transferred to Shareholders/Third party												$ 330
Amount of accrued interest transfered												$ 55
Interest rate on notes	8.00%																		8.00%
Principal amount converted	$ 105,000			$ 251,803													$ 69,698
Remaining principal of note																	$ 3,000	$ 3,000
6% Convertible Notes Payable [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes															January 2,012
Interest rate on notes															6.00%
Issued aggregate principal amount															$ 800
Converted note 110 [Member]
Convertible Notes Payable (Textual)
Shares issued on conversion of convertible notes											1,000,000	50,000					1,100,000
Principal amount converted											$ 100	$ 5					$ 110
Remaining principal of note																	$ 9,690
Description of conversion of convertible notes						The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 5,776,486 shares at June 30, 2016 and 3,506,665 shares at December 31, 2015.
Issuance of common shares																	11,025,605	3,506,665
Converted note 110 [Member] | Third Party [Member]
Convertible Notes Payable (Textual)
Shares issued on conversion of convertible notes											350,000
Principal amount converted											$ 35
Converted note additional 90 [Member]
Convertible Notes Payable (Textual)
Convertible notes payable to investor, Face amount																	$ 50,000
Shares issued on conversion of convertible notes							900,000	900,000	900,000							900,000
Principal amount converted							$ 90	$ 90	$ 90							$ 90
Remaining principal of note																	125
Description of conversion of convertible notes																The holder of the note has the right to convert the principal into shares of the Company's common stock at any time 180 days after the closing date at $0.0001 per share.
$240 Note [Member]
Convertible Notes Payable (Textual)
Conversion rate													$ 0.0006
Shares issued on conversion of convertible notes													400,000
Principal amount converted													$ 240
Remaining principal of note																	$ 60	$ 60
Description of conversion of convertible notes																		The notes plus any accrued but unpaid interest are convertible at the rate of $0.0001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 5,776,486 shares at June 30, 2016 and 3,506,665 shares at December 31, 2015.
Issuance of common shares																	5,776,486	3,506,665
$25,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes														November 2,012
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock														9.99%
Retired amount of notes													$ 14,000
Interest rate on notes														6.00%
Conversion rate														$ 0.001
Shares issued on conversion of convertible notes														1,010,000
Principal amount converted														$ 1,010
Description of conversion of convertible notes														The note plus any accrued but unpaid interest were convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock.
Issued aggregate principal amount														$ 25,000
$300 Note [Member]
Convertible Notes Payable (Textual)
Shares issued on conversion of convertible notes													300,000
Principal amount converted												$ 4,475	$ 300
Remaining principal of note													$ 9,690
$400 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																		9.99%
Interest rate on notes																		3,506,665
Conversion rate						$ 0.001				$ 0.001								$ 0.0001
Shares issued on conversion of convertible notes										400,000
Principal amount converted										$ 400
$700 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																	9.99%
Principal amount transferred to Shareholders/Third party										$ 1,000
Conversion rate												$ 0.001					$ 0.001
Shares issued on conversion of convertible notes		700,000										700,000
Principal amount converted		$ 700										$ 700
Remaining principal of note																	$ 2,075	$ 2,075
Description of conversion of convertible notes												The note plus any accrued but unpaid interest are convertible at the rate of $0.001 per share at the time of conversion up to a maximum of 9.99% of the then issued and outstanding common stock, or 5,776,486 shares at June 30, 2016 and 3,506,665 shares at December 31, 2015.
Issuance of common shares																	11,025,605	3,506,665
$1,100 Note [Member]
Convertible Notes Payable (Textual)
Note conversion, maximum shares issuable in percentage of issued and outstanding common stock																	9.99%
Conversion rate																	$ 0.001
Shares issued on conversion of convertible notes						1,100,000
Principal amount converted						$ 1,100
$3,000 Note [Member]
Convertible Notes Payable (Textual)
Maturity of convertible notes					October 2,015
Interest rate on notes					8.00%
Conversion rate					$ 0.0001
Shares issued on conversion of convertible notes			3,000,000
Principal amount converted			$ 3,000
Remaining principal of note																	$ 715	$ 3,715
Issued aggregate principal amount					$ 3,000

Convertible Note Payable (Detai

Convertible Note Payable (Details Textual 2) - USD ($)	May 02, 2016	Jan. 07, 2016	Oct. 08, 2015	Sep. 21, 2016	Aug. 31, 2015	Jul. 31, 2015	Sep. 30, 2016	May 31, 2016	Mar. 07, 2016	Dec. 31, 2015	Jun. 12, 2015
8% Convertible notes payable (Textual)
Convertible notes payable to investor, Face amount										$ 477,666
Interest rate on notes		8.00%							8.00%
Maturity date		Jan. 7, 2017					Jul. 2, 2012
Remaining principal of note							$ 3,000			$ 3,000
Original issue, Discount							(8,491)
8% Convertible Notes Payable [Member]
8% Convertible notes payable (Textual)
Convertible notes payable to investor, Face amount	$ 60,000		$ 31,000	$ 6,000	$ 38,000	$ 59,000		$ 60,000
Interest rate on notes	8.00%		8.00%		8.00%	8.00%
Maturity date	May 2, 2017		Oct. 8, 2016	Oct. 8, 2016	Mar. 31, 2016	Mar. 31, 2016
Conversion date, description	Beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.		The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.		Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.	Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.
Remaining principal of note				$ 25,000			$ 38,000
Original issue, Discount			$ 1,500								$ 100,000

Convertible Notes Payables (D40

Convertible Notes Payables (Details Textual 3)

May 02, 2016USD ($)

Jan. 13, 2016USD ($)

Jan. 07, 2016USD ($)Segment$ / shares

Oct. 15, 2015USD ($)

Oct. 08, 2015USD ($)

Sep. 27, 2016USD ($)

Sep. 21, 2016USD ($)

Aug. 31, 2015USD ($)

Jul. 31, 2015USD ($)

Jun. 30, 2015

Sep. 30, 2016USD ($)shares

May 11, 2016USD ($)

Jun. 30, 2016USD ($)

Jun. 15, 2016USD ($)

May 31, 2016USD ($)

Mar. 15, 2016USD ($)

Mar. 07, 2016

Dec. 31, 2015USD ($)

Sep. 30, 2015USD ($)

Jun. 12, 2015USD ($)

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

$ 477,666

Interest rate on notes

8.00%

8.00%

Maturity date

Jan. 7, 2017

Jul. 2, 2012

Sale of convertible redeemable principal amount

$ 46,803

$ 50,000

$ 100,000

Original issue, Discount

$ (8,491)

Proceeds from discount on legal fees

$ 75,697

Beneficial ownership interest rate

9.99%

Convertible notes payable

293,930

180,393

Remaining principal of note

3,000

$ 3,000

Common Stock [Member]

5% Convertible notes payable (Textual)

Conversion rate | $ / shares

$ 55

Common stock conversion of trading days | Segment

20

Remaining principal of note

$ 105,000

Investor [Member]

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

$ 57,750

50,000

Interest rate on notes

8.00%

Maturity date

May 2, 2017

Conversion date, description

The holder of the note is entitled, at its option beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

Sale of convertible redeemable principal amount

$ 251,803

Debt instrument convertible redeemable description

(i) a convertible redeemable note in principal amount of $105,000 containing an original issue discount of $20,000 (the "$105K Note"); and (ii) a convertible redeemable note in principal amount of $50,000 (the "$50K Note" and together with the $105K Note, the "Notes").

collateralized secured promissory note

$ 50,000

Note receivables

(46,803)

$ (50,000)

Remaining principal of note

$ 57,750

50,000

$ 46,803

5% CONVERTIBLE NOTES PAYABLE

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

$ 35,000

$ 35,000

$ 100,000

Interest rate on notes

5.00%

5.00%

Maturity date

Oct. 15, 2016

Dec. 31, 2015

Conversion date, description

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 50% of the average of the three lowest market trading prices during the 3 days immediately preceding the conversion date.

Original issue debt discount

$ 5,000

Debt discounted rate, Percentage

55.00%

Sale of convertible redeemable principal amount

60,000

Original issue, Discount

4,733

Convertible notes payable

Remaining principal of note

$ 40,000

$ 100,000

$ 40,000,000

Replacement note amount

50,000

$ 50,000

Convertible Note Payable-SO-B (8%) (Original $60k) [Member]

5% Convertible notes payable (Textual)

Convertible notes payable to investor, Face amount

$ 60,000

$ 31,000

$ 6,000

$ 38,000

$ 59,000

$ 60,000

Interest rate on notes

8.00%

8.00%

8.00%

8.00%

Maturity date

May 2, 2017

Oct. 8, 2016

Oct. 8, 2016

Mar. 31, 2016

Mar. 31, 2016

Conversion date, description

Beginning on the 6 month anniversary, to convert all or any of the principal face amount of the Note then outstanding into shares of the Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

The note holder has the right at any time to convert any part or all of the outstanding unpaid principal balance into shares of the Company's common stock at the discounted rate of 58% of the lowest market trading price during the 20 days prior to and including the conversion date.

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

Beginning 180 days following the closing date the note holder shall have the right to convert any or all of the outranking principal balance into shares of the Company's common stock at the discounted rate of 55% of the average of the three lowest market trading prices during the 10 days immediately preceding the conversion date.

Convertible notes payable converted into common stock | shares

37,579

Original issue, Discount

$ 1,500

$ 100,000

Convertible notes payable

$ 22,421

Remaining principal of note

$ 25,000

$ 38,000

Convertible Note Payable-SO-B (8%) (Original $60k) [Member] | Investor [Member]

5% Convertible notes payable (Textual)

Convertible notes payable converted into common stock | shares

97,120,990

Derivatives and Fair Value In41

Derivatives and Fair Value Instruments (Details)	9 Months Ended
	Sep. 30, 2016
6/30/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	172.00%
7/12/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	213.00%
7/15/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	217.00%
7/18/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	203.00%
7/16/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	220.00%
7/20/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	215.00%
7/25/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	212.00%
7/28/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	212.00%
8/19/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	184.00%
9/13/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	172.00%
9/21/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	98.00%
9/30/2016 [Member]
Projected annual volatility for each valuation period
Volatility rate	128.00%

Derivatives and Fair Value In42

Derivatives and Fair Value Instruments (Details 1) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2016	Jun. 30, 2016	Sep. 30, 2016	Dec. 31, 2015
Summary of convertible notes payable
Principal Note Amount				$ 477,666
Original Derivitive Valuation				478,626
Derivative Valuation	$ 532,693	$ 350,644	$ 363,977	$ 157,617
Conversions	(10,151)	(42,034)	(99,387)
Mark to Market	60,163	(204,139)	112,720
Issuances		64,124
8% Convertible Note Payable-issued 10/8/2015 [Member]
Summary of convertible notes payable
Derivitive Treatment Date				Oct. 8, 2015
Maturity Date				Oct. 8, 2015
Principal Note Amount				$ 31,000
Original Derivitive Valuation				58,779
Derivative Valuation	52,163	31,186	19,807	$ 56,366
Conversions			(7,521)
Mark to Market	(4,203)	(20,977)	(3,858)
5% Convertible Note Payable-issued 6/12/15 [Member]
Summary of convertible notes payable
Derivitive Treatment Date				Dec. 9, 2015
Maturity Date				Dec. 12, 2015
Principal Note Amount				$ 100,000
Original Derivitive Valuation				37,827
Derivative Valuation	32,293	29,564	56,156	$ 35,176
Conversions		(11,835)	(24,318)
Mark to Market	(2,883)	9,106	50,910
8% Convertible Note Payable-issued 6/25/15 [Member]
Summary of convertible notes payable
Derivitive Treatment Date				Dec. 22, 2015
Maturity Date				Jan. 7, 2017
Principal Note Amount				$ 59,000
Original Derivitive Valuation				56,956
Derivative Valuation	59,209	41,032		$ 66,075
Conversions	(10,151)	(8,604)	(46,218)
Mark to Market	3,285	9,573	5,186
8% Convertible Notes Payable- issued January 7, 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date				Jan. 7, 2016
Maturity Date				Jan. 7, 2017
Principal Note Amount				$ 105,000
Original Derivitive Valuation				87,287
Derivative Valuation	127,206	68,693	84,629
Conversions
Mark to Market	39,919	(58,513)	15,936
8% Convertible Notes Payable- issued January 7 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date				Jan. 7, 2016
Maturity Date				Jan. 7, 2017
Principal Note Amount				$ 50,000
Original Derivitive Valuation				68,124
Derivative Valuation	89,897	54,386	67,916
Conversions
Mark to Market	21,773	(35,511)	13,530
8% Convertible Notes Payable- issued March 7, 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date				Mar. 7, 2016
Maturity Date				Mar. 7, 2017
Principal Note Amount				$ 50,000
Original Derivitive Valuation				87,538
Derivative Valuation	88,709	53,840	69,145
Conversions
Mark to Market	1,171	(34,869)	15,305
8% Convertible Notes Payable- issued March 7 2016 [Member]
Summary of convertible notes payable
Derivitive Treatment Date				Mar. 7, 2016
Maturity Date				Jan. 7, 2017
Principal Note Amount				$ 46,803
Original Derivitive Valuation				82,115
Derivative Valuation	83,216	50,718	65,114
Conversions
Mark to Market	1,101	(32,498)	14,396
8% Convertible Notes Payable-issued March 7, 2016 [Member].
Summary of convertible notes payable
Derivitive Treatment Date				Apr. 4, 2016
Maturity Date				Jan. 7, 2017
Principal Note Amount				$ 35,863
Original Derivitive Valuation
Derivative Valuation		21,225	1,210
Conversions		(21,595)	(21,330)
Mark to Market		(21,304)	1,315
Issuances		$ 64,124

Derivatives and Fair Value In43

Derivatives and Fair Value Instruments (Details Textual) - USD ($)	9 Months Ended
	Sep. 30, 2016	Mar. 07, 2016	Jan. 07, 2016	Aug. 19, 2015	Jun. 25, 2015	Jun. 12, 2015
Derivatives and Fair Value Instruments (Textual)
Derivative, description	An event of default for the Convertible Note would occur 0% of the time, increasing 1.00% per month to a maximum of 5.0%;- Alternative financing for the Convertible Note would be initially available to redeem the note 0% of the time and increase monthly by 1% to a maximum of 10%;
Monthly trading volume	$ 126,178
Description of embedded derivative	The monthly trading volume would average $88,182 and would increase at 5% per month;ownership limits conversion across LG's 6 notes based on 4.99% with shares outstanding increasing monthly by 1%.
Interest rate on convertible notes		8.00%	8.00%
Equity Method Investment, Ownership Percentage	4.99%			100.00%
Maximum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	220.00%
Stock price	$ 0.0071
Variable conversion rate	58.00%
Variable conversion price	$ 0.0073
Derivatives trading preiod	20 days
Derivatives effective rate	51.81%
Minimum [Member]
Derivatives and Fair Value Instruments (Textual)
Projected annual volatility	98.00%
Stock price	$ 0.0152
Variable conversion rate	50.00%
Derivatives trading preiod	3 days
Derivatives effective rate	43.09%
5% Convertible Note Payable-issued 6/12/15 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes						5.00%
8% Convertible Note Payable-issued 6/25/15 [Member]
Derivatives and Fair Value Instruments (Textual)
Interest rate on convertible notes					8.00%

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	Aug. 09, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Sep. 30, 2016	Dec. 31, 2015
Stockholders' Equity (Textual)
Common stock, shares authorized		1,500,000,000			1,500,000,000	1,500,000,000
Common stock, par value		$ 0.0001			$ 0.0001	$ 0.0001
Common stock, shares outstanding		110,366,413			110,366,413	35,101,750
Common stock, shares issued		110,366,413			110,366,413	35,101,750
Common stock issued for services, shares	3,000,000
Convertible preferred stock description					The Series B preferred stock has no voting rights. The holders of the Series B convertible preferred stock have the right to convert the same into Common Stock of the Corporation at the ratio of one (1) share of Series B Convertible Preferred for five hundred (500) shares of Common Stock.
Issuance of Series B Preferred shares as payment for inventory				$ 50,000
Shares issue for services		$ 0.01			$ 0.01
Common stock value		$ 11,037			$ 11,037	$ 3,510
Common Stock [Member]
Stockholders' Equity (Textual)
Common stock, shares authorized		1,500,000,000			1,500,000,000	1,500,000,000
Common stock, par value		$ 0.0001			$ 0.0001	$ 0.0001
Common stock, shares outstanding		110,366,413			110,366,413	35,101,750
Common stock, shares issued		110,366,413			110,366,413	35,101,750
Common stock issued for services, shares						3,500,000
Issuance of Series B Preferred shares as part consideration for license agreement, shares
Issuance of common shares upon conversion of shares			1,700,000	1,700,000
Issuance of Series B Preferred shares as payment for inventory
Common stock value		$ 5,000			$ 5,000
March 31, 2015 One [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.001			$ 0.001
Common stock, shares issued		2,000,000			2,000,000
March 31, 2015 Two [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0005			$ 0.0005
Common stock, shares issued		800,000			800,000
March 31, 2015 Three [Member]
Stockholders' Equity (Textual)
Cancellation of common shares to recapitalize company (Shares)					500,000
June 30, 2015 [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0005			$ 0.0005
Common stock, shares issued		2,300,000			2,300,000
September 30, 2015 [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0005			$ 0.0005
Common stock, shares issued		3,800,000			3,800,000
September 30, 2015 One [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.015			$ 0.015
Common stock, shares issued		20,000			20,000
Percentage of aquisition					100.00%
September 30, 2015 Two [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.01			$ 0.01
Common stock, shares issued		500,000			500,000
Officers Compensation [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.01			$ 0.01
Common stock, shares issued		3,000,000			3,000,000
December 31, 2015 [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.01			$ 0.01
Common stock, shares issued		500,000			500,000
December 31, 2015 One [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.01			$ 0.01
Common stock, shares issued		200,000			200,000
March 31, 2016 [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.00275			$ 0.00275
Common stock, shares issued		1,095,036			1,095,036
March 31, 2016 One [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.00275			$ 0.00275
Common stock, shares issued		1,285,560			1,285,560
March 31, 2016 Two [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.003355			$ 0.003355
Common stock, shares issued		906,533			906,533
March 31, 2016 Three [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.00275			$ 0.00275
Common stock, shares issued		1,500,000			1,500,000
March 31, 2016 Four [Member]
Stockholders' Equity (Textual)
Common stock, shares issued		1,700,000			1,700,000
Stock issued during period shares issued for conversion of of notes, shares					3,400
June 30, 2016 [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares					1,950,000
Issuance of Series B preferred shares as payment for inventory, shares					3,900
Stock issued during period shares issued for conversion of of notes, shares					1,584,873
Stock issued during period shares issued for conversion of of notes, per shares					$ 0.0033
June 30, 2016 One [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares		1,100,000
Issuance of Series B preferred shares as payment for inventory, shares		2,200
Stock issued during period shares issued for conversion of of notes, shares		2,194,200
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0033
June 30, 2016 Two [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares		1,700,000
Issuance of Series B preferred shares as payment for inventory, shares		3,400
Stock issued during period shares issued for conversion of of notes, shares		2,000,000
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0044
June 30, 2016 Three [Member]
Stockholders' Equity (Textual)
Issuance of common shares upon conversion of shares		4,000
Issuance of Series B preferred shares as payment for inventory, shares		20,000
Stock issued during period shares issued for conversion of of notes, shares		2,500,000
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0029
June 30, 2016 Four [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		783,062
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0038
June 30, 2016 Five [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		768,026
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0036
June 30, 2016 Six [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		853,643
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0028
June 30, 2016 Seven [Member] | Consultant [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.01			$ 0.01
Common stock issued for services, shares					500,000
Series A preferred stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized		1,000,000			1,000,000	1,000,000
Preferred stock, par value		$ 0.0001			$ 0.0001	$ 0.0001
Preferred stock, shares issued		50,000			50,000	50,000
Preferred stock, shares outstanding		50,000			50,000	50,000
Common stock issued for services, shares					100	100
Series B Preferred Stock [Member]
Stockholders' Equity (Textual)
Preferred stock, shares authorized		50,000			50,000	50,000
Preferred stock, par value		$ 0.0001			$ 0.0001	$ 0.0001
Preferred stock, shares issued		26,100			26,100	0
Preferred stock, shares outstanding		26,100			26,100	0
Issuance of Series B Preferred shares as part consideration for license agreement, shares					25,000
Issuance of common shares upon conversion of shares					12,900
Issuance of Series B preferred shares as payment for inventory, shares					10,000
Series B Preferred Stock [Member] | Consultant [Member]
Stockholders' Equity (Textual)
Common stock issued for services, shares					500,000
Series B Preferred Stock [Member] | March 31, 2016 Five [Member]
Stockholders' Equity (Textual)
Preferred stock, shares issued		10,000			10,000
Issuance of Series B Preferred shares as payment for inventory					$ 50,000
Series B Preferred Stock [Member] | June 30, 2016 Three [Member]
Stockholders' Equity (Textual)
Issuance of Series B Preferred shares as part consideration for license agreement, shares		3,400

Stockholders' Equity (Details45

Stockholders' Equity (Details Textual 1) - $ / shares	Aug. 09, 2016	Sep. 30, 2016	Dec. 31, 2015
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0001	$ 0.0001
Common stock issued for services, shares	3,000,000
September 30, 2016 [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		1,356,747
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.002915
September 30, 2016 One [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,500,000
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.002915
September 30, 2016 Two [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,213,714
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0029
September 30, 2016 Three [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,213,714
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.002915
September 30, 2016 Four [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		3,180,000
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.002915
September 30, 2016 Five [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		3,352,874
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.002915
September 30, 2016 Six [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		1,194,500
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.002915
September 30, 2016 Seven [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		3,333,073
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.00352
September 30, 2016 Eight [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,693,624
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0039
September 30, 2016 Nine [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,886,003
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.003465
September 30, 2016 Ten [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,995,816
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0029
September 30, 2016 Eleven [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,226,772
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0029
September 30, 2016 Twelve [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,400,000
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0005
September 30, 2016 Thirteen [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		3,000,000
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.001
September 30, 2016 Fourteen [Member]
Stockholders' Equity (Textual)
Stock issued during period shares issued for conversion of of notes, shares		2,516,666
Stock issued during period shares issued for conversion of of notes, per shares		$ 0.0028
September 30, 2016 Fifteen [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0092
Common stock issued for services, shares		4,000,000
September 30, 2016 Sixteen [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0083
Common stock issued for services, shares		3,000,000
September 30, 2016 Seventeen [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0083
Common stock issued for services, shares		2,000,000
September 30, 2016 Eighteen [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0078
Common stock issued for services, shares		500,000
September 30, 2016 Nineteen [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0065
Common stock issued for services, shares		2,000,000
September 30, 2016 Twenty [Member]
Stockholders' Equity (Textual)
Common stock, par value		$ 0.0083
Common stock issued for services, shares		2,000,000

Commitments and Contingencies46

Commitments and Contingencies (Details)	9 Months Ended
	Sep. 30, 2016
Consultant - FDA requirements and compliance
Commitments And Contingencies [Line Items]
Commitment	$2000 per month
Term	12 years
Consultant - capital formation and market services
Commitments And Contingencies [Line Items]
Commitment	Various equity percentage issuances of restricted stock for fundings
Term	6 years
Consultant - tradeshow attendence, strategy and collaboration, cordination regarding FDA compliance, manuafacturing operations, sales and marketing, other related services
Commitments And Contingencies [Line Items]
Commitment	$10,000 per month (payable quarterly in cash or common stock from the 2016 Equity Incentive Plan)
Term	12 years

Commitments and Contingencies47

Commitments and Contingencies (Details Textual) - USD ($)	Sep. 12, 2016	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Commitments and contingencies (Texual)
Current office space rate per month		$ 1,575		$ 1,575
Commitments description				The Company also has ready-to-go office space available to be used for meetings etc. at a nominal cost of approximately $100 per month with no commitment.
Payments for rent		325		$ 347
Rent expense		2,247	$ 1,872	6,039	$ 6,087
Office premises cost	$ 650
Lease agreement renewal term	3 years
Office premises cost term	1 year
Stockholder [Member]
Commitments and contingencies (Texual)
Current office space rate per month		$ 525		$ 525

Income Taxes (Details)

Income Taxes (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Reconciliation of income tax rate [Abstract]
Statutory federal income tax rate	34.00%	34.00%
State income taxes, net of federal taxes	9.00%	9.00%
Valuation allowance	(43.00%)	(43.00%)
Effective income tax rate	0.00%	0.00%

Income Taxes (Details Textual)

Income Taxes (Details Textual)	9 Months Ended
	Sep. 30, 2016USD ($)
Income Taxes (Textual)
Net operating loss carryforward	$ 1,553,512
Operating loss carryforwards expiration period, description	Reduce future federal taxable income which begins to expire in the year 2030.

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015
Owed amount of related parties
Due to related party	$ 8,921	$ 8,921	$ 8,921
Due to Officer/Stockholder	8,446		8,446
Due to other Stockholders	4,090		49,300
Total Related Party Obligations	$ 21,457		$ 66,667

Related Party Transactions (D51

Related Party Transactions (Details Textual) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Aug. 31, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Feb. 29, 2016	Aug. 19, 2015
Related Party Transaction [Line Items]
Base compensation			$ 18,974		$ 18,974		$ 30,000
Fair value of acquired entity										$ 20
Impairment of Trademark	$ 20,000			$ 20,000		$ 20,000
Voting right per share			$ 0.01		$ 0.01
Officer's compensation			$ 25,000	$ 25,000	$ 75,000	$ 75,000
Converted into shares of common stock					25,721,665
Series B Preferred Stock
Related Party Transaction [Line Items]
Issuance of Series B Preferred shares as part consideration for license agreement, shares					25,000
Issuance of common shares upon conversion of shares					3,400
Converted into shares of common stock					1,700,000
Settlement of liability					10,000
Promissory Note [Member]
Related Party Transaction [Line Items]
Promissory note issued by company			150,000		$ 150,000				$ 7,000
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Base compensation			15,000		15,000
Officer's compensation							$ 100,000	$ 100,000
Accrued payroll			$ 10,000		$ 10,000
Medical Lasers Manufacturer, Inc. [Member]
Related Party Transaction [Line Items]
Percentage of aquisition		100.00%
Common stock shares issued for acquisition		20,000
Price per share		$ 0.015
Fair value of acquired entity		$ 20,000
Purchase of inventory		$ 50,000
Acquisition of MLM, description		MLM acquired a trademark from the son of the Company's President for $20,000 due 90 days from the date of acquisition.

Basis of Reporting - Going Co52

Basis of Reporting - Going Concern (Details)	9 Months Ended
	Sep. 30, 2016USD ($)
Basis of Reporting (Textual)
Net losses	$ 1,779,549

Stock Compensation - Equity I53

Stock Compensation - Equity Incentive Plan (Details) - shares	Aug. 09, 2016	Sep. 30, 2016
Stock Compensation Equity Incentive Plan (Textual)
Common stock to non-employees for services rendered	3,000,000
2016 Equity Incentive Plan [Member]
Stock Compensation Equity Incentive Plan (Textual)
Aggregate of maximum shares of common stock		20,000,000
Common stock to non-employees for services rendered	4,000,000	8,000,000
Issuance of common shares		12,000,000

Derivatives and Fair Value In54

Derivatives and Fair Value Instruments (Details 2) - USD ($)	3 Months Ended	6 Months Ended	9 Months Ended
	Mar. 31, 2016	Jun. 30, 2016	Sep. 30, 2016
Derivatives and Fair Value Instruments [Abstract]
Mark-to market fair value adjustment	$ 60,163	$ (204,139)	$ 112,720
Total mark-to market fair value adjustment			$ (31,256)

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

Nov. 08, 2016

Nov. 06, 2016

Oct. 13, 2016

Oct. 12, 2016

Oct. 11, 2016

Oct. 06, 2016

Aug. 11, 2016

Aug. 09, 2016

Jan. 07, 2016

Oct. 21, 2016

Jan. 31, 2016

Sep. 30, 2016

Dec. 31, 2015

Jun. 15, 2016

Mar. 15, 2016

Sep. 30, 2015

Jun. 12, 2015

Subsequent Event Textual [Abstract]

Outstanding convertible notes converted into shares amount

$ 105,000

$ 251,803

$ 69,698

Principal balance due remaining amount

$ 46,803

$ 50,000

$ 100,000

Promissory note issued

$ 100

$ 100

Debt Instrument, Maturity Date

Jan. 7, 2017

Jul. 2, 2012

Original issue, Discount

$ (8,491)

Common issued for services

$ 35,000

Common stock issued for services, shares

3,000,000

Consultant [Member]

Subsequent Event Textual [Abstract]

Common stock issued for services, shares

500,000

2016 Equity Incentive Plan [Member]

Subsequent Event Textual [Abstract]

Common issued for services

$ 16,500

Common stock issued for services, shares

4,000,000

8,000,000

Subsequent Event [Member]

Subsequent Event Textual [Abstract]

Outstanding convertible notes converted into shares amount

$ 11,500

$ 12,500

$ 12,500

$ 12,500

Convertible notes payable converted into common stock

5,750,000

5,705,841

5,000,000

3,696,081

Principal balance due remaining amount

$ 26,000

$ 37,500

$ 12,500

Promissory note issued

$ 3,000

Interest bearing percentage

8.00%

Accrued interest

$ 1,068

Warrant exercise price

$ 0.02

Consulting warrants shares

1,250,000

Warrant exercisable term

18 months

Warrant exercises per month

$ 3,000

Subsequent Event [Member] | Restricted Stock [Member]

Subsequent Event Textual [Abstract]

Compensation agreement

2,000,000

Subsequent Event [Member] | Consultant [Member]

Subsequent Event Textual [Abstract]

Common stock issued for services, shares

2,000,000

Subsequent Event [Member] | Consultant [Member] | Restricted Stock [Member]

Subsequent Event Textual [Abstract]

Common stock issued for services, shares

3,500,000

Subsequent Event [Member] | 2016 Equity Incentive Plan [Member]

Subsequent Event Textual [Abstract]

Common issued for services

$ 10,000

Common stock issued for services, shares

2,000,000

Subsequent Event [Member] | Replacement Note [Member]

Subsequent Event Textual [Abstract]

Principal balance due remaining amount

$ 50,000

Debt Instrument, Maturity Date

Mar. 27, 2018

Debt Instrument, Interest Rate, Effective Percentage

9.00%

Description of conversion of convertible notes

Company's common stock at the price equal to 55% of the lowest trading price for the twenty prior trading days including the date of conversion.

Subsequent Event [Member] | Convertible Note [Member]

Subsequent Event Textual [Abstract]

Principal balance due remaining amount

$ 157,895

Debt Instrument, Maturity Date

Mar. 27, 2018

Debt Instrument, Interest Rate, Effective Percentage

9.00%

Original issue, Discount

$ 7,895

Description of conversion of convertible notes

Company's common stock at the price equal to 57.5% of the lowest trading price for the twenty prior trading days including the date of conversion.